EurekaMag PDF full texts Chapter 35,366

Bondeson, J.; Brennan, F.M.; Foxwell, B.M.J.; Feldmann, M. 1999: NF- kappaB dependent pathways of matrix metalloproteinase induction in rheumatoid arthritis. Arthritis and Rheumatism 42(9 Suppl): S198

Baldwin, A.; Canhoto, A.J.; Pirisi, L.; Creek, K.E. 2001: NF-1 binding sites mediate transforming growth factor-beta inhibition of the human papillomavirus type 16 early promoter. Proceedings of the American Association for Cancer Research Annual Meeting 42: 117

Monaco Kushner, M.C.G.; Frye, S.; Sabath, B.F.; Durham, L.C.; Major, E.O. 2000: NF-1 class D and its role in JCV replication. Journal of Neurovirology 6(5): 426

Arai, K.I.; Liu, J. 2004: NF-AT derived polypeptides that bind calcineurin and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1285(4)

Crabtree, G.R.; Northrop, J.P.; Ho, S.N. 2000: NF-AT polynucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)

Crabtree, G.R.; Northrop, J.P.; Ho, S.N. 2000: NF-AT polypeptides and polynucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1240(3)

Crabtree, G.R.; Northrop, J.P.; Ho, S.N.; Flanagan, W.M. 2002: NF-AT polypeptides and polynucleotides and screening methods for immunosuppressive agents. Official Gazette of the United States Patent and Trademark Office Patents 1256(1)

Glimcher, L.H.; Hodge, M.R. 1999: NF-AT-interacting protein NIP45 and methods of use therefor. Official Gazette of the United States Patent and Trademark Office Patents 1218(2): 1261

Kacena, M.A.; Shivdasani, R.A.; Gundberg, C.M.; White, D.W.; Chen, Y.; Orkin, S.H.; Horowitz, M.C. 2000: NF-E2 and GATA-1 deficient mice, new models of bone formation. Journal of Bone and Mineral Research 15(Suppl 1): S151

Yuan, X.H.; Liu, Y.; Clayman, G.L.; Chen, Z. 1999: NF-IL6 and its complex regulate E6 promoter function in oral and cervical squamous cell carcinomas. Proceedings of the American Association for Cancer Research Annual Meeting 40: 634

Yang, Z.; Wara Aswapati, N.; Chen, C.; Tsukada, J.; Auron, P.E. 2000: NF-IL6 vigorously activates il1b gene expression via a Spi-1 protein-protein tether. Journal of Biological Chemistry 275(28): 21272-21277

Moretti, F.; Palescandolo, E.; Serra, C.; Vossio, S.; Costanzo, A.; Levrero, M. 2004: NF-KB activation via tyrosine phoshorylation of I-KB-alpha results in the selective modulation of the NF-KB transcriptome and activation of progenitor cells markers. Journal of Hepatology 40(Suppl 1): 19

Baba, M.; Ono, M. 2000: NF-KB activity inhibitor. Official Gazette of the United States Patent and Trademark Office Patents 1238(4)

Lessard, L.; Mes Masson, A.M.; Lattouf, J.B.; Lamarre, L.; Saad, F. 2003: NF-KB nuclear localization may predict recurrence following radical prostatectomy. Journal of Urology 169(4 Suppl): 85-86

Hardwick, J.C.; Van Deventer, S.J.; Peppelenbosch, M.P. 2000: NF-Kappa B and JNK are highly expressed and active in the stromal cells of human colonic adenomatous polyps. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A879

Lin, H.; Zhai, J.; Nie, Z.; Wu, J.; Ge, W.; Meinkoth, J.L.; Schlaepfer, W.W.; Canete Soler, R. 2003: NF-L RNA gain-of-function on motor neurons. FASEB Journal 17(4-5): Abstract 406

Su, M.; Mantovani, R.; Sodek, J. 2003: NF-Y mediated transcription of Bone Sialoprotein gene. Calcified Tissue International 72(4): 440

Jean, D.; Guillaume, N.; Frade, R. 2002: NF-Y, SP1 and SP3 transcription factors are involved in the regulation of human cathepsin L promoter. FASEB Journal 16(4): A667

Morotti, A.; Cilloni, D.; Pautasso, M.; Messa, F.; Gottardi, E.; Saglio, G. 2002: NF-kB Inhibitors as New Approaches in the Molecular Therapy of Leukemias. Blood 100(11): Abstract No. 4182

Mulkins, M.A.; Morham, S.G.; Smithies, O.; Swinney, D.C. 1999: NF-kB activation and cytokine production in fibroblasts deficient in both isoforms of prostaglandin H synthase. FASEB Journal 13(7): A1504

Tani, K.; Adachi, M.; Hasegawa, A.; Kanda, N.; Watanabe, S. 2003: NF-kB activation by Candida albicans in human keratinocytes Possible involvement of toll-like receptor 2 but not TLR4. Journal of Investigative Dermatology 121(1): 1035

Lysiak, J.J.; Bang, H.J.; Nguyen, Q.A.T.; Turner, T.T. 2004: NF-kB activation following ischemia/reperfusion injury in the testis. Journal of Andrology (Suppl S): 83

Sakai, T.; Whitten, C.W.; Hill, G.E.; Greilich, P.E.; Giesecke, A.H. 1999: NF-kB activation is a possible mechanism for proinflammatory cytokines release during cardiopulmonary bypass. Anesthesiology 91(3A): A63

Adams, V.; Spaete, U.; Kraenkel, N.; Schuler, G.; Hambrecht, R. 2002: NF-kB activation is involved in inflammatory skeletal muscle alterations in patients with chronic heart failure. Journal of the American College of Cardiology 39(5 Suppl A): 175A-176A

Fouad, Dalia; Siendones, Emilio; Montero, Jose Luis; De La Mata, Manuel; Muntane, Jordi; Mino, Gonzalo 2002: NF-kB activation is involved on PGE1 protection against D-galactosamine-induced apoptosis in primary culture of rat hepatocytes. Journal of Hepatology 36(Suppl 1): 79

Cho, K.; Koh, C.; Lee, D.; Lee, J.; Joo, C. 1999: NF-kB activation mediated cellular death in lens epithelial cells after ultraviolet irradiation. IOVS Investigative Ophthalmology and Visual Science 40(4): S519

Fox, J.; Rogers, A.; Whary, M.; Ge, Z.; Taylor, N.; Xu, S.; Horwitz, B.; Erdman, S. 2003: NF-kB deficient mice infected with WT C jejuni have gastroenteritis but not mice infected with C jejuni mutants lacking cytolethal-distending toxin. IJMM International Journal of Medical Microbiology 293(Suppl 35): 68

Xing, L.P.; Carlso, L.; Story, B.; Tai, Z.; Sibenlist, U.; Boyce, B. 2000: NF-kB expression is required for IL-1-induced bone resorption. Journal of Bone and Mineral Research 15(Suppl 1): S154

Seitz, C.S.; Freiberg, R.A.; Khavari, P.A. 1999: NF-kB function determines localization and features of programmed cell death in epidermis. Journal of Investigative Dermatology 112(4): 526

Strehlau, J.; Schnakenburg, C.V.; Schachter, A.D.; Strasburg, A.; Latta, K.; Offner, G.; Enke, B.; Ehrich, J.H.H. 1999: NF-kB gene activation but not cyclosporine or FK506 trough levels indicate inadequate blocking of CTL-mediators in treatment refractory acute rejection and nephrotic syndrome. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 714A

Butcher, H.L.; Koropatnick, D.J. 2000: NF-kB in metallothionein-knockout fibroblasts Consequences of transfection of MT expression vectors. Proceedings of the American Association for Cancer Research Annual Meeting 41: 403

Beswick, R.A.; Dorrance, A.N.; Rajagopalan, S.; Webb, R.C. 2000: NF-kB inhibition lowers blood pressure in mineralocorticoid hypertensive rats. Hypertension 36(4): 692

Brink Van Den, G.R.; Rive, M.M.; Deventer Van, S.J.H.; Peppelenbosch, M.P. 1999: NF-kB is highly expressed and activated in both normal and the inflamed proliferating gastric epithelium. Gastroenterology 116(4 Part 2): A864

Thangasamy, A.; Mohan, S. 2002: NF-kB mediated inhibition of apoptosis in vascular smooth muscle cells contribute to accelerated atherosclerosis in diabetes. Free Radical Biology and Medicine 33(Suppl 2): S406

Biondo, C.; Abu Amer, Y. 2002: NF-kB mediates inflammatory bone erosion in autoimmune rheumatoid arthritis. Journal of Bone and Mineral Research 17(Suppl 1): S161

L.F.rla, K.; Hellwig Buergel, T.; Jelkmann, W. 2002: NF-kB negatively regulates erythropoietin expression in inflammation. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 78

Hinata, K.; Khavari, P.A. 2000: NF-kB regulates epithelial proliferation and cell death along with the effector genes mediating these processes. Journal of Investigative Dermatology 114(4): 771

Mycko, M.P.; Berkowicz, T.; Kaminska, B.; Walczak, A.; Glabinski, A.; Raine, C.S.; Selmaj, K. 1999: NF-kB role in autoimmune demyelination Selective NF-kB inhibition leads to exacerbation of EAE. Neurology 52(6 Suppl 2): A339-A340

Bhakar, A.; Zeindler, C.; Macpherson, S.; Barker, P.A. 1999: NF-kB transcriptional activity in intact brain and primary neurons Analysis of a transgenic reporter strain. Society for Neuroscience Abstracts 25(1-2): 2272

Cilloni, D.; Messa, F.; Morotti, A.; Messa, E.; Fava, M.; Gottardi, E.; Saglio, G. 2002: NF-kB transcriptional factor is involved in the regulation of the Wilms tumor gene expression. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 109

Wang, X.C.; Saban, R.; Kaysen, J.H.; Saban, M.R.; Allen, P.L.; Benes, E.N.; Hammond, T.G. 2000: NF-kB-dependent upregulation of neurokinin-1 receptors in a mouse model of LPS-induced cystitis. Journal of Urology 163(4 Suppl): 61

Gervin, A.M.; Memet, S.; Freiberg, R.A.; Israel, A.; Khavari, P.A. 1999: NF-kB-directed transcription is normally localized to non-proliferating cells within epidermis and is strongly induced by ultraviolet injury but not by wounding. Journal of Investigative Dermatology 112(4): 530

Zhou, D.; Yu, T.; Chen, G.; Brown, S.A.; Thompson, J.S. 2000: NF-kB1 gene knockout attenuates ionizing radiation-induced in vivo NF-kB activation and IL-1a, IL-1b and IL-6 mRNA expression. FASEB Journal 14(6): A1110

Demeritt, I.B.; Milford, L.E.; Yurochko, A.D. 2003: NF-kappa B A potential mediator of Human Cytomegalovirus-induced inflammation. Journal of Leukocyte Biology Suppl: 43

Schmid, Johannes A.; Birbach, Andreas; Novak, Sonja; Hofer, Erhard; Binder, Bernd R.; De Martin, Rainer 2001: NF-kappa B and upstream signaling kinases shuttle constitutively between cytoplasm and nucleus. FASEB Journal 15(5): A1053

Laurent, S.; Lebrun, V.; Van Den Berge, V.; Saliez, V.; Sempoux, C.; Horsmans, Y.; Lambotte, L. 2000: NF-kappa B is not essential for proliferation of hepatocytes after Partial Hepatectomy in rats. Hepatology 32(4 Pt 2): 479A

Mohan, R.R.; Mohan, R.R.; Kim, W.J.; Wilson, S.E. 1999: NF-kappa B modulation of corneal fibroblast apoptosis. IOVS Investigative Ophthalmology and Visual Science 40(4): S193

Tak, P.P.; Firestein, G.S. 2001: NF-kappaB: a key role in inflammatory diseases. Journal of Clinical Investigation 107(1): 7-11

Ghosh, S. 2000: NF-kappaB A mediator of innate immune responses. Journal of Endotoxin Research 6(2): 75

Choi, J.S.; Song, K.J.; Yoon, S.K.; Gwag, B.J.; Chun, M.H.; Joo, C.K. 1999: NF-kappaB activation and its role in axotomized rat retina. Society for Neuroscience Abstracts 25(1-2): 758

Chan, E.L.; Haudek, S.B.; Murphy, J.T. 2000: NF-kappaB activation and regulation of TNF-alpha mRNA transcription in microvascular vs macrovascular endothelial cells. FASEB Journal 14(4): A413

Zamanian, M.; Mogensen, T.H.; Williams, B.R.G. 1999: NF-kappaB activation by dsRNA is dependent on the dsRNA-activated protein kinase and mediated through IkappaB kinase. Journal of Interferon and Cytokine Research 19(Suppl 1): S132

Cao, Z.; Goeddel, D.V.; Yamaguchi, K.; Tanaka, M.; Hezi Yamit, A.; Fuentes, M.; Dalrymple, S.; Wu, L.; Li, Y.; Schreiber, B. 2000: NF-kappaB activation by pro-inflammatory cytokines. Scandinavian Journal of Immunology 51(Suppl 1): 24

Kanai, M.; Konda, Y.; Nakajima, T.; Izumi, Y.; Ida, H.; Chiba, T. 2000: NF-kappaB activation by transforming growth factor A prevents apoptosis of gastric mucous cell. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A820

Lysiak, J.J.; Bang, H.J.; Nguyen, Q.A.T.; Turner, T.T. 2004: NF-kappaB activation following ischemia/reperfusion injury in the testis. Journal of Andrology Suppl (Suppl): 83

Amit, S.; Ben-Neriah, Y. 2003: NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach. Seminars in Cancer Biology 13(1): 15-28

Carlotti, F.; Yang, L.; Dower, S.K.; Qwarnstrom, E.E. 1999: NF-kappaB activation in single living cells - Analysis of anti-apoptosis and kinetics of activation by IL-1beta. Biochemical Society Transactions 27(3): A94

D.P., I.G.; Tan, X.; Wang, L.; Chang, H.; Liu, Q.P.; Hsueh, W. 1999: NF-kappaB activation induced by LPS is PAF-independent in intestinal epithelial cells. Pediatric Research 45(4 Part 2): 110A

Altman, A.; Villalba, M.; Englund, N.; Coudronniere, N. 2000: NF-kappaB activation induced by TCR/CD28 costimulation is mediated by PKC-theta. FASEB Journal 14(6): A1175

Baccam, M.; Bishop, G.A. 1999: NF-kappaB activation is not sufficient, and binding of TRAFS2 and 3 is not required, for CD40-mediated IL-6 production in B cells. FASEB Journal 13(5 Part 2): A988

Du, Y.; Bales, K.R.; Dodel, R.C.; Gao, F.; Liu, X.; Yan, G.M.; Little, S.P.; Paul, S.M. 1999: NF-kappaB activation mediates both neuroprotective and pro-apoptotic fates in cultured cerebellar granule neurons. Society for Neuroscience Abstracts 25(1-2): 2058

Kwak, H.B.; Lawler, J.M.; Song, W.; Tidball, J.G. 2003: NF-kappaB activity and iNOS protein expression are upregulated in skeletal muscle of mdx mice. FASEB Journal 17(4-5): Abstract 809

Chintala, S.K.; Wang, N.; Schuman, J.S.; Fini, M.E. 2000: NF-kappaB activity in normal and glaucomatous trabecular meshwork cells. IOVS Investigative Ophthalmology and Visual Science 41(4): S506

Probyn, M.E.; Hooper, S.B.; Dargaville, P.A.; Mccallion, N.; Nicholas, T.L.; Harding, R.; Morley, C.J. 2002: NF-kappaB activity in the lungs of preterm lambs ventilated with different strategies from birth. Pediatric Research 51(4 Part 2): 353A

Luhm, J.; Frohn, C.; Schlenke, P.H.; Rink, L.; Fischer, A.; Kirchner, H.; Koritke, P. 2000: NF-kappaB and NF-AT in NK cells differ in structure and kinetics from those of other lymphocytes. Immunobiology 203(1-2): 76

Sanchez, A.; Nagy, P.; Schroeder, I.S.; Factor, V.M.; Thorgeirsson, S.S. 2003: NF-kappaB and STAT-3 are required for hepatic stem cell activation. Hepatology 38(4 Suppl 1): 283A

Nakshatri, H.; Goulet, R.J. 2002: NF-kappaB and breast cancer. Current Problems in Cancer 26(5): 282-309

Joyce, D.; Albanese, C.; Steer, J.; Fu, M.; Bouzahzah, B.; Pestell, R.G. 2001: NF-kappaB and cell-cycle regulation: the cyclin connection. Cytokine and Growth Factor Reviews 12(1): 73-90

Siegler, R.L.; Pysher, T.J. 2002: NF-kappaB and neutrophils in post-diarrheal HUS. Kidney International 62(3): 1088-1090

Hatano, E.; Bradham, C.A.; Bennett, B.L.; Brenner, D.A. 1999: NF-kappaB and nitric oxide protect primary mouse hepatocytes from Fas-mediated apoptosis. Hepatology 30(4 Part 2): 416A

O'sullivan, A.W.; Wang, J.H.; O'malley, D.B.; Redmond, H.P. 2002: NF-kappaB and p38 MAPK inhibition do not alter cytokine release or wound healing in endotoxin shock. Journal of Endotoxin Research 8(3): 187

Mitsiades, N.; Mitsiades, C.S.; Poulaki, V.; Chauhan, D.; Hideshima, T.; Treon, S.P.; Anderson, K.C. 2001: NF-kappaB and p38 kinase as novel therapeutic targets for human multiple myeloma. Blood 98(11 Part 1): 376a-377a

Hatada, E.N.; Krappmann, D.; Scheidereit, C. 2000: NF-kappaB and the innate immune response. Current Opinion in Immunology 12(1): 52-58

Tomita, N.; Morishita, R.; Tomita, T.; Azuma, H.; Ogihara, T. 2003: NF-kappaB as a therapeutic target for transcription factor decoy strategy in inflammatory diseases. Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents 2(1): 51-56

Dajee, M.; Lazarov, M.; Khavari, P. 2002: NF-kappaB blockade and oncogenic Ras induce invasive human epidermal neoplasia by circumventing cell cycle arrest. Journal of Investigative Dermatology 119(1): 220

Russo, M.P.; Boubreau, F.; Li, F.; Panja, A.; Traber, P.G.; Sartor, R.B.; Jobin, C. 2001: NF-kappaB blockade exacerbates experimental colitis in transgenic mice expressing an intestinal epithelial cell specific IkappaB super-repressor. Gastroenterology 120(5 Suppl 1): A 70

Luedde, T.; Assmus, U.; Wuestefeld, T.; Pasparakis, M.; Manns, M.P.; Trautwein, C. 2004: NF-kappaB can be activated by IKK-2 independent pathways in the liver. Journal of Hepatology 40(Suppl 1): 7

Hashizume, M.; Tomita, N.; Notake, M.; Fujitani, B.; Toyosawa, K.; Morishita, R.; Lan, H.Y.; Higaki, J.; Kaneda, Y.; Hosoki, K.; Ogihara, T. 1999: NF-kappaB decoy prevents the progression of anti-GBM glomerulonephritis in rats. Japanese Journal of Pharmacology 79(Suppl 1): 268P

Takase, O.; Marumo, T.; Uchimura, H.; Asai, M.; Hishikawa, K.; Hayashi, M.; Saruta, T. 2003: NF-kappaB dependent genes induced by proteinuria. Journal of the American Society of Nephrology 14(Abstracts Issue): 557A-558A

Williams, E.S.; Wilson, E.; Ramos, K.S. 2003: NF-kappaB dysregulation in atherosclerotic vascular smooth muscle cells Complex composition and redox sensitivity. Toxicological Sciences 72(S-1): 11

Adib Conquy, M.; Adrie, C.; Moine, P.; Asehnoune, K.; Fitting, C.; Pinsky, M.; Dhainaut, J.F.; Cavaillon, J.M. 2000: NF-kappaB expression in mononuclear cells of septic patients resembles that observed in LPS-tolerance. Journal of Endotoxin Research 6(2): 116

Caamaño, J.; Hunter, C.A. 2002: NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clinical Microbiology Reviews 15(3): 414-429

Strehlau, J.; Schnakenburg, C.V.; Schachter, A.D.; Strasburg, A.; Offner, G.; Latta, K.; Enke, B.; Filler, G.; Ehrich, J.H.H. 1999: NF-kappaB gene activation in acute rejection and treatment refractory nephrotic lesions indicates ineffective blocking of cytotoxic mediator generation by steroids, cyclosporin and FK506. Pediatric Nephrology 13(7): C23

Lin, A.; Karin, M. 2003: NF-kappaB in cancer: a marked target. Seminars in Cancer Biology 13(2): 107-114

Butcher, H.L.; Koropatnick, J. 2001: NF-kappaB in metallothionein-knockout and wild-type fibroblasts Consequences of transfection of MT expression vectors. Proceedings of the American Association for Cancer Research Annual Meeting 42: 95

Mattson, M.P.; Camandola, S. 2001: NF-kappaB in neuronal plasticity and neurodegenerative disorders. Journal of Clinical Investigation 107(3): 247-254

Jones, E.; Bourne, T.; Adcock, I.; Paul, C.; Punchard, N.A. 2000: NF-kappaB in the TNBS model of colonic inflammation. Immunology 101(Suppl 1): 88

Li, J.; Volsky, D.J.; Ghorpade, A.; Canki, M. 2003: NF-kappaB independent induction of MCP-1 and rantes during productive infection of human fetal astrocytes by HIV-1. Journal of Neurovirology 9(Suppl 3): 73

Spyridopoulos, I.; Hipp, M.S.; Froehlich, K.U.; Mayer, P.; Axel, D.I. 2000: NF-kappaB independent transactivation of interleukin-8 is specific for human arterial endothelial cells. Circulation 102(18): 2; 175-II 176

Singh, V.P.; Bhagat, L.; Hietaranta, A.J.; Song, A.M.; Pan, A.; Van Acker, G.J.D.; Mykoniatis, A.; Steer, M.L.; Saluja, A.K. 2000: NF-kappaB independent upregulation of Mob-1 mRNA expression in rat pancreas following supramaximal stimulation with caerulein. Pancreas 21(4): 480

Barajas, M.A.; Boya, P.; Brenner, D.; Qian, C.; Prieto, J. 2000: NF-kappaB inhibition increases TNF-alpha and etoposide mediated apoptosis in the hepatoma cell line PLC/PFR/5. Journal of Hepatology 32(Suppl 2): 85

Furukawa, Y.taka; Kobuke, Kazuhiro; Nunokawa, Youichi; Yamaki, Akira; Kinoshita, Makoto; Uchiyama, Kouji; Touma, Masanao; Matsumori, Akira 2002: NF-kappaB inhibition reduces pro-inflammatory molecule expression and attenuates atherosclerosis in apoE-/- mice. Circulation 106(19): II41

Liu, H.; Lo, C.R.; Czaja, M.J. 2001: NF-kappaB inhibition sensitizes hepatocytes to TNF-alpha-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 34(4 Pt 2): 248A

Nunokawa, Y.; Nakatsuka, T.; Saitoh, M.; Abe, K. 2004: NF-kappaB inhibitor comprising an indan derivative as an active ingredient. Official Gazette of the United States Patent and Trademark Office Patents 1282(2)

Yamanaka, T.; Shiraki, K.; Inoue, H.; Ito, T.; Sugimoto, K.; Sakai, T.; Ohmori, S.; Wagayama, H.; Fujikawa, K.; Takase, K.; Nakano, T. 2000: NF-kappaB inhibitor suppresses TNF-alpha and chemotherapeutic agents-induced apoptosis in HepG2 cells. Gastroenterology 118(4 Suppl 2 Pt 2): AASLD A150

Lopez Franco, O.; Suzuki, Y.; Navarro, E.; Sanjuan, G.; Blanco, J.; Yo, Y.; Kopp, J.; Mampaso, F.; Egido, J.; Gomez Guerrero, C. 2001: NF-kappaB inhibitors as potential novel anti-inflammatory agents for the treatment of experimental nephritis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 684A

Jacobo Herrera, N.J.; Bremner, P.D.; Gibbons, S.; Heinrich, M. 2003: NF-kappaB inhibitors from Valeriana officinalis L, an important European medicinal plant. South African Journal of Botany 69(2): 255

Gao, F.; Bales, K.R.; Dodel, R.C.; Cordell, B.; Paul, S.M.; Du, Y. 1999: NF-kappaB inhibitors modulates Abeta/cytokine-induced release of alpha2 macroglobulin from glia cells. Society for Neuroscience Abstracts 25(1-2): 1349

Kataoka, Y.; Murley, J.S.; Grdina, D.J. 2003: NF-kappaB inhibitors prevent the induction of MnSOD in HMEC and mouse Sa-NH cells exposed to amifostine. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1011

Sang, H.; Wallis, G.L.; Stewart, C.A.; Tabatabaie, T.; Kotake, Y. 2000: NF-kappaB inhibitors, PBN and PDTC protect mice from hapten-induced colitis through interleukin-10 over-expression. Free Radical Biology and Medicine 29(Suppl 1): S50

Zhang, W.; Kone, B.C. 2002: NF-kappaB inhibits transcription of the H/K-ATPase alpha2 subunit gene in mIMCD3 cells Role of histone deacetylase-6. American Journal of Physiology 283(5 Part 2): F904-F911

Hong, C.Y.; Choi, H.S.; Soh, J.; Lee, K. 2003: NF-kappaB interacts with the orphan nuclear receptor Nur77 to regulate the expression of steroidogenic enzyme genes in Leydig cells. Biology of Reproduction 68(Suppl 1): 193

Kang, S.; Cho, S.; Burger, J.; Shao, Y.; Chung, J.; Fisher, G.J.; Voorhees, J.J. 2002: NF-kappaB is activated and proinflammatory cytokines and matrix degrading enzymes are induced in inflammatory acne lesions in vivo. Journal of Investigative Dermatology 119(1): 235

Miyoshi, H.; Rust, C.; Gores, G.J. 2000: NF-kappaB is activated in cholestasis and functions in a cytoprotective role. Gastroenterology 118(4 Suppl 2 Pt 1): AASLD A101

Chase, A.J.; Newby, A.C. 2001: NF-kappaB is essential for metalloproteinase secretion by smooth muscle cells and foam cells. Clinical Science (London) 101(2): 22P

Meng, C.; Chow, P.; Lee, K. 2001: NF-kappaB is essential for zygotic development. Development Growth and Differentiation 43(Suppl): S99

Van Den Brink, G.R.; Rive, M.M.; Ponsioen, C.; Vandeventer, S.J.H.; Peppelenbosch, M.P. 1999: NF-kappaB is highly expressed and activated in both normal and the inflamed proliferating gastric epithelium. Immunology Letters 69(1): 51

Durham, W.; Farid, M.; Reid, M.B. 2003: NF-kappaB is inhibited in vivo by oral curcumin. FASEB Journal 17(4-5): Abstract 809

Chen, X.; Shen, B.; Xia, L.; Khaletzkiy, A.; Chu, D.; Young, M.; Colburn, N.; Wong, J.; Li, J.J.an 2001: NF-kappaB is involved in the development of radio-resistance in human keratinocytes transfected with human papillomavirus. Proceedings of the American Association for Cancer Research Annual Meeting 42: 665

Konson, A.; Azab, A.N.; Rimon, G.; Danon, A.; Agbaria, R. 2002: NF-kappaB is probably not involved in cyclooxygenase-2 overexpression in murine colon cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 549-550

Mceleny, K.R.; William, R.; Watson, G.; Coffey, R.N.T.; Fitzpatrick, J.M.; Muenchen, H.J. 2001: NF-kappaB manipulation of cIAP-2 alters apoptosis in LNCaP cells. Journal of Urology 165(5 Suppl): 50

Tamae, D.; Wang, T.; Li, J.J.an 2003: NF-kappaB mediated ERK regulation in ionizing radiation induced stress responses. Free Radical Biology and Medicine 35(Suppl 1): S152

Paskas, S.; Buryskova, M.; Burysek, L.; Simmet, T. 2003: NF-kappaB mediated activation of the protease activated receptor 1 promoter. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R17

Guo, G.; Wang, T.; Tamas, D.; Chen, T.; Huang, T.T.; Ogi, J.; Spitz, D.R.; Oberley, L.W.; Li, J.J. 2002: NF-kappaB mediated manganese superoxide dismutase in radiation induced adaptive responses. Free Radical Biology and Medicine 33(Suppl 2): S428

Hadjisavva, I.S.; Patierno, S.R.; Kennedy, K.A. 2003: NF-kappaB mediated stress-induced resistance to the topoisomerase II inhibitor etoposide in human cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1303

Jung, Y.n Jin; Lee, S.; Liu, Z.G.; Birrer, M.; Trepel, J.; Neckers, L. 2002: NF-kappaB mediates HIF-1alpha induction by TNF-alpha in normoxic cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1023

Kriehuber, E.; Charbonnier, A.S.; Jaksits, S.; Winter, D.; Stingl, G.; Maurer, D. 2001: NF-kappaB mediates T cell dependent Langerhans cell survival. Archives of Dermatological Research 293(1-2): 40

Brandes, L.M.; Boller, Y.C.; Lin, Z.P.; Patierno, S.R.; Kennedy, K.A. 2000: NF-kappaB mediates stress-induced resistance to etoposide. Proceedings of the American Association for Cancer Research Annual Meeting 41: 751

Menaa, C.; Turbov, J.; Froelich, C.J.; Fujishiro, M.; Asano, T.; Sprague, S.M. 2002: NF-kappaB mediates the production of osteoclastogenic factors by breast cancer cells. Journal of Bone and Mineral Research 17(Suppl 1): S186

Arinze, I.J.; Kawai, Y. 2002: NF-kappaB mediates transcriptional activation of the G i2 gene promoter during phorbol ester-induced differentiation of K562 cells to megakaryocytes. FASEB Journal 16(4): A9

Canaff, L.; Hendy, G.N. 2002: NF-kappaB mediates transcriptional up-regulation of the human calcium-sensing receptor gene by interleukin-1beta and tumor necrosis factor-alpha. Journal of Bone and Mineral Research 17(Suppl 1): S494

Canaff, L.; Hendy, G.N. 2003: NF-kappaB mediates transcriptional upregulation of the human calcium-sensing receptor gene by pro-inflammatory cytokines. FASEB Journal 17(4-5): Abstract 129

Jensen, P.; O'malley, K. 1999: NF-kappaB modulates tyrosine hydroxylase gene expression in response to stress. Society for Neuroscience Abstracts 25(1-2): 1502

D'souza, M.J.; Zuscik, M.J.; Eliseev, R.A.; Gunter, T.E.; Schwarz, E.M.; Puzas, J.E.; O'keefe, R.J.; Rosier, R.N. 2002: NF-kappaB over-expression protects growth plate chondrocytes from ionizing radiation-induced apoptosis. Journal of Bone and Mineral Research 17(Suppl 1): S408

Denis Donini, S.; Giambelli, R.; Caprini, A.; Grilli, M.G. 2000: NF-kappaB p50 involvement in tangential migration. Journal of Neurochemistry 74(Suppl ): S63

Mizgerd, J.P.; Lupa, M.M.; Spieker, M.R. 2001: NF-kappaB p50 represses LPS-induced gene expression and facilitates neutrophil emigration in the lungs. FASEB Journal 15(4): A157

Collins, T.; Cybulsky, M.I. 2001: NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?. Journal of Clinical Investigation 107(3): 255-264

Figueroa, Y.G.; Scandurro, A.B.; Tang, Y.; Beckman, B.S. 2001: NF-kappaB plays a key role in HIF-regulated erythropoietin gene expression. Experimental Hematology 29(8 Suppl 1): 81

Gutierrez, Y.I.; Scandurro, A.B.; Tang, Y.; Beckman, B.S. 2001: NF-kappaB plays a key role in HIF-regulated gene expression in human hepatocellular carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 899-900

Horwitz, B.H.; Refaeli, Y.; Hoffmann, A.; Edwards, T. 2000: NF-kappaB protects activated CD4+ T cells from killing by TNF. Pediatric Research 47(4 Part 2): 18A

Ge, B.; Li, O.; Feng, X.; Wilder, P.J.; Rizzino, A.A.; Mckeithan, T.W. 2003: NF-kappaB regulates BCL3 transcription in the Jurkat T-cell line through an intronic enhancer. FASEB Journal 17(7): C99

Ray, A.; Das, J.; Chen, C.H.; Cohn, L.; Ray, P. 2001: NF-kappaB regulates GATA-3 expression and Th2 differentiation but not T-bet expression or Th1 differentiation. FASEB Journal 15(4): A711

Kuwada, S.K.; Scaife, C.; Kuang, J.; Daynes, R. 2001: NF-kappaB regulates colon cancer cell proliferation and tumorigenicity. Gastroenterology 120(5 Suppl 1): A 615

Werrbach Perez, K.; Cole, K.; Glasgow, J.; Nesic, O.; Qiu, J.; Toliver Kinsky, T.; Spies, M.; Perez Polo, R. 2000: NF-kappaB role in stress response in CNS. Journal of Neurochemistry 74(Suppl ): S50

Dixit, V.; Mak, T.W. 2002: NF-kappaB signaling. many roads lead to madrid. Cell 111(5): 615-619

Aradhya, S.; Nelson, D.L. 2001: NF-kappaB signaling and human disease. Current Opinion in Genetics and Development 11(3): 300-306

Sun, S.C.; Xiao, G.; Uhlik, M.; Waterfield, M.; Harhaj, E.W.; Fong, A. 2001: NF-kappaB signaling triggered by the HTLV-I transactivator Tax. AIDS Research and Human Retroviruses 17(Suppl 1): S 5

Zotalis, G.; O'malley, S.; Gordon, A.H.; Schwarz, E.M.; O'keefe, R.J.; Rosier, R.N.; Puzus, J.E. 2000: NF-kappaB signalling and cytokines implicated in metastasis of prostatic adenocarcinoma to bone. Laboratory Investigation 80(3): 202A

Lee, C.L.; Hsu, K.M.; Lin, W.C.; Lin, C.C. 2002: NF-kappaB signals is downregulated in ground-based microgravity cultured lymphocytes. FASEB Journal 16(5): A1161-A1162

Foo, S.Y.; Nolan, G.P. 1999: NF-kappaB to the rescue: RELs, apoptosis and cellular transformation. Trends in Genetics: Tig 15(6): 229-235

Piette, J.; Schoonbroodt, S. 1999: NF-kappaB transcription factor activation in T-lymphocytes by oxidative stress. Free Radical Biology and Medicine 27(Suppl 1): S65

Denk, A.; Wirth, T.; Baumann, B. 2000: NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine and Growth Factor Reviews 11(4): 303-320

Devi, S.S.; Korrapati, M.C.; Mehendale, H.M. 2003: NF-kappaB, EGFR/MAPK downregulation may explain failed tissue repair in thioacetamide-treated diabetic rats. FASEB Journal 17(4-5): Abstract 385

Richmond, A. 2002: NF-kappaB, chemokine gene transcription and tumour growth. Nature Reviews Immunology 2(9): 664-674

Altinoz, M.A.; Korkmaz, R. 2004: NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma 51(4): 239-247

Hill Kapturczak, N.; Thamilselvan, V.; Liu, F.; Nick, H.S.; Agarwal, A. 2001: NF-kappaB-dependent induction of heme oxygenase-1 gene expression by curcumin in human renal proximal tubule cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 652A-653A

Florio, G.; Cianferoni, A.; Keen, J.C.; Schmidt, J.W.; Lakenan, W.A.; Georas, S.N.; Casolaro, V. 2000: NF-kappaB-dependent transcription of the human IL-13 gene in activated T cells. Journal of Allergy and Clinical Immunology 105(1 part 2): S278

Morand, E.F.; Sampey, A.V.; Lacey, D.; Hall, P.; Bucala, R. 2000: NF-kappaB-independent activation of rheumatoid arthritis synovial cells by MIF. Inflammation Research 49(Suppl 2): S102

Russo, M.; Allard, B.; Jobin, C. 2002: NF-kappaB-inducing kinase activates NF-kappaB transcriptional activity and proinflammatory gene expression through an I KB kinase -independent mechanism. Gastroenterology 122(4 Suppl 1): A 96

Matsumoto, M.; Yamada, T. 2001: NF-kappaB-inducing kinase dependent T cell activation. FASEB Journal 15(5): A1041

Natarajan, R.; Bai, W.; Yerneni, K.K.; Khan, B.V. 1999: NF-kappaB-mediated activation of inflammatory genes by oxidized fatty acids in vascular smooth muscle cells. Circulation 100(18): 1; 744

Green, N.S.; Perl, J. 2000: NF-kappaB-mediated stimulation of somatic mutation. FASEB Journal 14(6): A958

Zwacka, R.M.; Stark, L.A.; Robertson, P.; Dunlop, M.G. 1999: NF-kappaB-targeted gene therapy approaches for hepatic metastasis of colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 483

Steinle, A.; Weidenbach, H.; Adler, G.; Schmid, R.M. 1999: NF-kappaB/Rel activation prevents higher degree of damage in cerulein pancreatitis. Gastroenterology 116(4 Part 2): A1165

Schmid, R.M.; Adler, G. 2000: NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases. Gastroenterology 118(6): 1208-1228

Kurland, J.F.; Meyn, R.E. 2000: NF-kappaB1 homodimers regulate transcription of the bcl-2 oncogene in murine B-cell lymphoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 41: 775

Oswald, F.; Liptay, S.; Adler, G.; Schmid, R.M. 1999: NF-kappaB2 is a putative target gene for activated mammalian Notch-1 via RBP-Jkappa. European Journal of Cell Biology 78(Suppl 49): 69

Speirs, K.M.; Caamano, J.; Hunter, C.A.; Scott, P. 2000: NF-kappaB2 is required for the development of a protective Th1 response to Leishmania major. FASEB Journal 14(6): A985

Baltimore, D.; Alcamo, E.; Hoffmann, A.; Stankovski, I. 1999: NF-kappaBs many facets. FASEB Journal 13(7): A1429

Chen, S.; Ingram, D.A.; Fisher, L.; Wenning, M.J.; Yu, X.; Hock, J.; Clapp, D.W.de 2002: NF1 Plays and Essential Role in Osteoclasts Development and Its Survival. Blood 100(11): Abstract No. 295

Moncla, A.; Missirian, C.; Pincemaille, O.; Mancini, J.; Livet, M.O.; Malzac, P.; Philip, N. 1999: NF1 and overgrowth syndrome resembling Weaver syndrome in 3 sporadic patients. American Journal of Human Genetics 65(4): A335

Zhu, Y.an; Ghosh, Pritam; Charnay, Patrick; Burns, Dennis, K.; Parada, Luis, F. 2002: NF1 associated neurofibromas initiate through loss of NF1 function in Schwann cells and accelerate growth in response to a haploinsufficient environment. Proceedings of the American Association for Cancer Research Annual Meeting 43: 146

Lasota, J.; Wasag, B.; Millward, C.L.; Rys, J.; Sobin, L.H.; Miettinen, M. 2002: NF1 but not NF2 gene is altered in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas A molecular genetic study based on 14 cases. Laboratory Investigation 82(1): 134A

Dorschner, M.O.; Weaver, M.A.; Sybert, V.P.; Stephens, K.G. 1999: NF1 microdeletions are mediated by homologous recombination between duplicons. American Journal of Human Genetics 65(4): A30

Nakamura, M.; Okura, T.; Takata, Y.; Watanabe, S.; Yang, Z.H.; Kitami, Y.; Hiwada, K. 2000: NF1 negatively regulates Gadd153 expression in vascular smooth muscle cells. Hypertension 36(4): 705

Zhong, Y.; Guo, H.F. 2001: NF1 protein and its role in activation of adenylyl cyclase by PACAP38-like neuropeptides. Official Gazette of the United States Patent and Trademark Office Patents 1248(3)

Kapitanovic, S.; Cacev, T.; Pavelic, K.; Spaventi, R. 2002: NF1 tumor suppressor gene in colon cancer Loss of heterozygosity. International Journal of Cancer Suppl (13): 333-334

Kapitanovic, S.; Cacev, T.; Pavelic, K.; Spaventi, R. 2002: NF1 tumor suppressor gene in sporadic colon cancer. European Journal of Human Genetics 10(Suppl 1): 87

D.L.ca, A.; Buccino, A.; Gianni, D.; Lazzarino, A.I.; Mangino, M.; Giustini, S.; Richetta, A.; Divona, L.; Calvieri, S.; Mingarelli, R.; Dallapiccola, B. 2002: NF1-gene analysis based on denaturing high-performance liquid chromatography. American Journal of Human Genetics 71(4 Suppl): 374

Evans, G.R. 2002: NF2 Clinical features and management. Genetics in Medicine 4(3): 225

Evans, G. 2002: NF2 and mosaicism in cancer. Journal of Medical Genetics 39(Suppl 1): S21

Braun, K.; Rettinger, J.; Ganso, M.; Hildebrandt, C.; Nickel, P.; Schmalzing, G.; Lambrecht, G. 2001: NF449 The first subnanomolar P2 antagonist selective for recombinant rat P2X1 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): R35

Menke, K.; Horner, S.; Mahaut Smith, M.; Hildebrandt, C.; Kassack, M.; Nickel, P.; Lambrecht, G. 2003: NF449 and MRS2179 are useful tools to distinguish between P2X1 and P2Y1 receptors in human platelets. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R35

Badran, B.M.; Burny, A.; Willard Gallo, K.E. 2000: NFAT binds to an upstream region in the human CD3-gamma gene that is homologous to the NF-kappaB consensus sequences in the HIV-1 LTR. Journal of Human Virology 3(5): 265

D.M.so, N.A.; Haddad, F.; Baldwin, K.M. 2002: NFAT response elements are involved in the down-regulation of the MHC Type IIB gene in overloaded plantaris muscle. FASEB Journal 16(5): A759

Graef, I.A.; Chen, F.; Crabtree, G.R. 2001: NFAT signaling in vertebrate development. Current Opinion in Genetics and Development 11(5): 505-512

Rosenberg, P.; Martin, C.; Hutcheson, K.; Dimaio, M.; Garry, D.; Bassel Duby, R.; Williams, R.S.nders 2002: NFAT transcriptional response during mouse embryogenesis and striated muscle adaptation. Circulation 106(19): II19

Murphy, L.L.S.; Hughes, C.C.W. 2000: NFAT translocation is required for endothelial cell-induced resistance to cyclosporin. FASEB Journal 14(6): A1177

Sutliff, R.L.; Parker, J.D.; Pavlath, G.K.; Murphy, T.J. 2002: NFATc2 gene ablation enhances contractility and alters endothelium-dependent relaxation of the murine aorta. FASEB Journal 16(5): A822

Bushdid, P.B.; Osinska, H.; Waclaw, R.R.; Molkentin, J.D.; Yutzey, K.E. 2003: NFATc3 and NFATc4 are required for cardiac development and mitochondrial function. Circulation Research 92(12): 1305-1313

Sweet, T.; Sawaya, B.E.; Coyle Rink, J.; Du, L.; Khalili, K. 2002: NFBP, a novel human protein from glial cells that interacts the NF-kappaB subunits to modulate HIV-1 LTR. Journal of Neurovirology 8(Suppl 1): 20

Peters, K.L.; Jin, G.; Stark, G.R.; Sen, G.C. 2001: NFICB-independent signaling by dsRNA Involvement of PI-3 kinase. Journal of Interferon and Cytokine Research 24(Suppl 1): S 57

Ross, J.S.; Kallakury, B.V.S.; Sheehan, C.E.; Karikehalli, S.; Kaur, P.; Mosher, R.; Badola, S.; Gray, K. 2003: NFKB and IKBA protein expression in prostatic and renal carcinomas Correlation with disease outcome. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1069

Sarchielli, P.; Alberti, A.; Gallai, B.; Baldi, A.; Mazzotta, G. 2003: NFKB and inducible nitric oxide synthase mRNA and protein expression in monocytes from internal jugular venous blood of migraine without aura patients assessed during attacks. Cephalalgia 23(7): 573

Fradet, V.; Lessard, L.; Mes Masson, A.M.; Begin, L.R.; Perrotte, P.; Karakiewicz, P.I.; Saad, F. 2004: NFKB expression predicts biochemical recurrence in patients with positive margin prostate cancer. Journal of Urology 171(4 Suppl): 288

Wong, H.K.; Dennis, G.; Kammer, G.; Tsokos, G.C. 1999: NFkB abnormalities in lymphocytes from patients with systemic lupus erythematosus. FASEB Journal 13(5 Part 2): A957

Huang, X.R.; Kim, Y.G.; Suga, S.I.; Mazzali, M.; Kivlighn, S.; Johnson, R.J.; Lan, H.Y. 2000: NFkB activation and IL-1 expression in experimental uric acid nephropathy. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 490A

Hollmann, C.A.; Owens, T. 2003: NFkB and MAP kinase in CD40-mediated apoptosis. Proceedings of the American Association for Cancer Research Annual Meeting 44: 253

Canales, N.; Evazyan, T.; Sajadinia, B.; Tejura, M.; Jewett, A. 2003: NFkB inhibition in tumor cells contributes to dendritic cell activation and subsequent peripheral blood lymphocyte activation. FASEB Journal 17(7): C331

Wang, T.; Lafuse, W.P.; Zwilling, B.S. 2001: NFkappa B-mediated TLR2 gene expression requires the transcription factor Sp1. Journal of Leukocyte Biology Suppl: 49

Barrans, S.L.; Teasdale, J.; Tooze, R.; Owen, R.; Jack, A.S.; Morgan, G.J. 2002: NFkappaB Is Associated with Non-Germinal Center Diffuse Large B Cell Lymphoma and Is a Poor Prognostic Factor. Blood 100(11): Abstract No. 1363

Kukreja, R.C. 2002: NFkappaB activation during ischemia/reperfusion in heart: friend or foe?. Journal of Molecular and Cellular Cardiology 34(10): 1301-1304

Castro, P.; Machado, A.L.; Valenca, S.S.; Porto, L.C.; Walker, C.; Zuany Amorim, C.; Goncalves, D.M.raes, V.L. 2001: NFkappaB activation in alveolar macrophages from mice exposed to cigarette smoke. Inflammation Research 50(Suppl 3): S150

Iwai, T.; Kondo, Y.; Suzuki, E.; Oka, J.I.hiro 2002: NFkappaB activation in the rat hippocampus is accompanied by apoptosis but not LTP-impairment induced by beta-amyloid protein in a GLP-1-dependent manner. Japanese Journal of Pharmacology 88(Suppl 1): 93P

Pratt, C.; Kushwaha, N.; Bishop, T. 2000: NFkappaB activation is an early event in breast cancer-cell progression to hormone-independence. Proceedings of the American Association for Cancer Research Annual Meeting 41: 244

Reed, K.L.; Fruin, A.B.; Gower, A.C.; Stucchi, A.F.; Andry, C.D.; O'brien, M.J.; Becker, J.M. 2002: NFkappaB activation is an early inflammatory event that precedes the upregulation of the neurokinin-1 receptor, proinflammatory cytokines and adhesion molecules in dextran sulfate soduim -induced colitis in rats. Gastroenterology 122(4 Suppl 1): A-396

Jones, E.; Bourne, T.; Adcock, I.; Pereira, S.; Paul, C.; Punchard, N.A. 2001: NFkappaB activity and inflammation of the bowel. Inflammation Research 50(Suppl 3): S224

Monaco, C.; Paleolog, E.; Cheshire, N.; Feldmann, M. 2002: NFkappaB and IkB kinase-2 regulate tissue factor and cytokine production in human atherosclerotic plaques An analysis via adenoviral gene transfer. European Heart Journal 23(Abstract Suppl): 261

Monaco, C.; Andreakos, E.; Kiriakidis, S.; Cheshire, N.; Foxwell, B.; Paleolog, E.; Feldman, M. 2003: NFkappaB and IkappaB kinase-2 are essential for spontaneous and CD40 ligand-induced production of tissue factor, matrix metalloproteinases and cytokines in human atherosclerotic tissue Novel targets for therapeutic intervention. Clinical Science (London) 104(Suppl 49): 5P

Schwabe, R.F.; Brenner, D.A. 2001: NFkappaB and PI-3 kinase/Akt differentially regulate inflammatory gene expression, but not apoptosis in activated human hepatic stellate cells. Hepatology 34(4 Pt 2): 400A

Cole, K.; Izumi, T.; Mitra, S.; Perez Polo, J.R.gino 2000: NFkappaB control of APE/Ref-1 promoter activity in PC12 cells. Journal of Neurochemistry 74(Suppl ): S71

Ward, A.M.; Uzzo, R.G.; Novick, A.C.; Finke, J.H. 2000: NFkappaB degradation in T lymphocytes destined to undergo apoptosis is caspase 3 independent in renal cell carcinoma. Journal of Urology 163(4 Suppl): 113

Arlt, A.; Vorndamm, J.; Mueerkoester, S.; Schmidt, W.E.; Foelsch, U.R.; Schaefer, H. 2001: NFkappaB dependent resistance of gastrointestinal-tumor cells to chemotherapy. International Journal of Molecular Medicine 8(Suppl 1): S7

Hanrahan, N.J.; O'donnell, C.; Williams, D.P.; Pirmohamed, M.; Park, B.K. 2003: NFkappaB in human neutrophils Relationship between apoptosis and glutathione concentrations. British Journal of Clinical Pharmacology 55(4): 441

Arlt, A.; Huenermann Jansen, A.; Foelsch, U.R.; Schmidt, W.E.; Schaefer, H. 2000: NFkappaB inhibition in pancreatic carcinoma cells triggers apoptosis induced by VP16 or adriamycin. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A515

Schrum, L.W.; Brenner, D.A.; Rippe, R.A.; Behrns, K.E. 2000: NFkappaB inhibition results in cell cycle arrest prior to TNFalpha-induced hepatocyte apoptosis. Hepatology 32(4 Pt 2): 339A

Komine, M.; Muto, S.; Itai, A.; Tamaki, K. 2003: NFkappaB is a possible target to inhibit ultraviolet irradiation induced hypermelanosis. Journal of Investigative Dermatology 121(1): 1208

Zender, L.; Kuehnel, F.; Paul, Y.; Trautwein, C.; Kubicka, S.; Manns, M.P. 1999: NFkappaB mediates FAS upregulation in a model of adenoviral hepatitis. Hepatology 30(4 Part 2): 387A

Gill, J.S.; Windebank, A.J. 1999: NFkappaB mediates cell cycle disregulation in glioblastoma cell lines. Society for Neuroscience Abstracts 25(1-2): 1797

Bryan, C.L. 2000: NFkappaB message in dog lung autografts during reperfusion injury. Chest 118(4 Suppl): 138S

Knuefermann, P.; Shi, S.P.; Stetson, S.J.; Torre Amione, G.; Sivasubramanian, N. 2002: NFkappaB p50-p50 homodimers in failing human hearts and the occurrence of their high-affinity binding sites in the promoters of genes downregulated during heart failure reveal a global transcriptional repression mechanism. Circulation 106(19): II167

Poeppelmann, B.; Klimmek, K.; Schwarz, T.; Kulms, D. 2004: NFkappaB promotes UVB-induced apoptosis by downregulation of TRAF-proteins. Archives of Dermatological Research 295(8-9): 384

Poeppelmann, B.; Strozyk, E.; Schwarz, T.; Kulms, D. 2004: NFkappaB selectively enhances UVB-induced apoptosis via differential gene regulation. Journal of Investigative Dermatology 123(2)

Gordon, A.H.; Mollano, A.V.; Lu, A.P.; Andela, V.; Zotalis, G.; Rosier, R.N.; Schwarz, E.M.; Romano, P.; O'keefe, R.J.; Puzas, J.E. 1999: NFkappaB signaling controls cytokine secretion and associated bone resorptive capacity of breast cancer cells. Journal of Bone and Mineral Research 14(Suppl 1): S153

Metheny Barlow, L.J.; Yu, J.; Li, L.Y.an 2003: NFkappaB transcriptional activity during VEGI-mediated endothelial growth arrest. Proceedings of the American Association for Cancer Research Annual Meeting 44: 604

Lim, M.J.; Chiang, E.T.; Shepro, D. 1999: NFkappaB translocation in human microvessel endothelial cells Improved resolution with a high throughput four compartment subcellular redistribution assay. FASEB Journal 13(5 Part 2): A864

Gladden, J.B.; Shetty, S.; Gibson, S.B. 2002: NFkappaB up-regulates both pro-apoptotic death receptor 5 and anti-apoptotic Mc1-1 proteins in the same cell line but NFkappaB binding to the DR5 promoter is not sufficient to activate its transcription during apoptosis. Molecular Biology of the Cell 13(Suppl): 243a-244a

Arlt, A.; Schäfer, H. 2002: NFkappaB-dependent chemoresistance in solid tumors. International Journal of Clinical Pharmacology and Therapeutics 40(8): 336-347

Abeyama, K.; Bergstresser, P.R.; Takashima, A. 2000: NFkappaB-dependent cytokine secretion by XS106 Langerhans cell line in response to UV radiation. Journal of Investigative Dermatology 114(1): 237

Xiao, C.W.; Tsang, B.K. 2000: NFkappaB-mediated induction of flice-like inhibitory protein by tumor necrosis factor-alpha in rat granulosa cells. Biology of Reproduction 62(Suppl 1): 201

Tyler, K.L.; Clarke, P.; Gibson, S.B.; Widmann, C.; Johnson, G.L. 2000: NFkappaB-regulated expression of cell death receptors DR4, DR5, and their ligand TRAIL mediates viral apoptosis. Neurology 54(7 Supp 3): A322

D'angio, C.T.; Lomonaco, M.B.; Chaudhry, S.B.; Finkelstein, J.N. 2000: NFkappab, NF-IL-6 and AP-1 transcription factors in oxygen induction of interleukin-8 in the macrophage. Pediatric Research 47(4 Part 2): 355A

Freston, J.; Taubel, J.; Lukasik, N.; Pan, W.J.; Chiu, Y.L. 2000: NG lansoprazole or IV pantoprazole Which provides better pH control?. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A659

Sharma, V.K.; Taubel, J.; Griffin, J.; Chiu, Y. 2000: NG lansoprazole/simplified lansoprazole suspension achieves faster control of intragastric acidity than IV pantoprazole. American Journal of Gastroenterology 95(9): 2465

Hodson, H.F. 1999: NG-monomethyl-L-argine hydrochloride derivatives and their use in the treatment of septic shock. Official Gazette of the United States Patent and Trademark Office Patents 1218(1): 488

Perner, A.; Sorensen, S.; Rask Madsen, J. 2000: NG-monomethyl-L-arginine inhibits colonic fluid secretion and nitric oxide production in collagenous colitis. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A809

Dawson, N.J.; Lawson, K. 2000: NG-nitro-L-arginine methyl ester attenuates the vasorelaxations to DY-9708, but not cromakalim, in rat isolated aortic rings. British Journal of Pharmacology 131(Proceedings Suppl December): 175P

Moroe, H.; Honda, H.; Arai, K.; Taniguchi, J.; Inamura, T.; Notoya, Y.; Kogo, H. 2002: NG-nitro-L-arginine-and indomethacin -resistant endothelium-dependent relaxation to acetylcholine in hypercholesterolemic rabbit renal artery and effects of pioglitazone on the relaxation. Japanese Journal of Pharmacology 88(Suppl 1): 249P

Cañete, E.; Campàs, M.òn.; de la Iglesia, P.; Diogène, J. 2010: NG108-15 cell-based and protein phosphatase inhibition assays as alternative semiquantitative tools for the screening of lipophilic toxins in mussels. Okadaic acid detection. Toxicology in Vitro: An International Journal Published in Association with Bibra 24(2): 611-619

Westphal, Johan R.; Van Kraats, Annemieke; De Groot Besseling, Renate; Ruers, Theo; Ruiter, Dirk; De Waal, Rob 2003: NG2 expression is lost during melanoma progression. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1250

Chekenya, M.; Pilkington, G.J. 2003: NG2 precursor cells in neoplasia: functional, histogenesis and therapeutic implications for malignant brain tumours. Journal of Neurocytology 31(6-7): 507-521

Ozerdem, U.; Monosov, E.; Stallcup, W.B. 2002: NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvascular Research 63(1): 129-134

Cattaruzza, S.; Ragni, M.; Russo, S.; Wasserman, B.; Colombatti, A.; Perris, R. 2003: NG2 proteoglycan modulates the convergence of ECM and growth factor-induced cell signalling in soft tissue sarcomas. International Journal of Molecular Medicine 12(Suppl 1): S51

Nishiyama, A.; Wu, Q. 1999: NG2+ glial progenitor cells in normal adult brain and in the dysmyelinating mutant jimpy. Uyemura, K, Kawamura, K, Yazaki, T Keio University Symposia for Life Science and Medicine; Neural development 339-344

Midwood, K.S.; Salter, D.M. 1999: NG2/HMPG modulates human articular chondrocyte interaction with type VI collagen. Journal of Pathology 187(Suppl): 13A

Beaton, A.R.; Sathe, S.; Sack, R.A.; Sathe, S.; Lee, K.; Gould, M. 2000: NGAL and MMP-9 in tear fluid. IOVS Investigative Ophthalmology and Visual Science 41(4): S672

Landau, S. 2000: NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)

Kalo, E.; Sarid, R.; Brodie, C. 2004: NGF Functions As A Pro-apoptotic Factor In PC-12 Cells Infected With Sindbis Virus. FASEB Journal 18(4-5): Abstract 790

Castiglioni, F.; Tagliabue, E.; Somenzi, G.; Ghirelli, C.; Menard, S. 2000: NGF activates the growth of human breast carcinoma cells cooperating with p185HER2. Tumori 86(4 Suppl 1): 28

Gentry, J.J.; Casaccia Bonnefil, P.; Highfield, H.; Carter, B.D. 1999: NGF activation of NFkappaB through the p75 receptor promotes survival. Society for Neuroscience Abstracts 25(1-2): 762

Cartier, L.; Albrecht, D.; Vergara, C.; Garcia, L.; Kettlum, A.; Collados, L.; Valenzuela, M. 2003: NGF and FGF-2 in CSF and in spinal cord from TSP/HAM patients. AIDS Research and Human Retroviruses 19(Suppl): S-37

Levi Schaffer, F.; Micera, A.; Mechoulam, H.; Aloe, L.; Pe'er, J. 2001: NGF and NGFR expression in inflamed juvenile conjunctival nevus A novel link among eosinophils, mast cells, and conjunctival nevus cells. IOVS Investigative Ophthalmology and Visual Science 42(4): S520

Bloch, J.; Borkenhagen, M.; Tseng, J.L.; Zurn, A.D.; Aebischer, P. 1999: NGF and NT-3 releasing guidance channels promote regeneration of the transected dorsal root. Society for Neuroscience Abstracts 25(1-2): 1002

Nicolodi, M.; Spillantini, M.G.; Sicuteri, F.; Del Bianco, E. 2003: NGF and SP in the saliva of migraine sufferers using FANs daily. Cephalalgia 23(7): 641

Kanwal, S.; Araki, T.; Milbrandt, J.; Carter, B.D. 1999: NGF and TNF upregulate ninjurin via activation of NFkappaB. Society for Neuroscience Abstracts 25(1-2): 2278

Efsen, E.; Bonacchi, A.; Petrai, I.; Rosini, P.; Torcia, M.; Pinzani, M.; Gentilini, P.; Marra, F. 2002: NGF and Trk-A as a novel autocrine loop in the early stages of hepatic stellate cell activation. Journal of Hepatology 36(Suppl 1): 70

Procoli, A.; Bracci Laudiero, L.; Celestino, D.; Rumi, C.; Picardi, A.; Bonini, S.; Aloe, L. 2003: NGF and TrkA expression in human cord blood CD34 positive cells. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S151

Chaturvedi, R.K.; Agrawal, A.K.; Shukla, S.; Seth, K.; Chauhan, S.; Seth, P.K. 2004: NGF and VMC co-transplantaion Functional restoration in 6-OHDA lesioned rat model of Parkinsons disease. Journal of Neurochemistry 88(Suppl 1): 88

Salvarezza, S.B.; Masco, D.H. 2001: NGF and bFGF induce neuronal survival by differential activation of signal transduction pathways in a subpopulation of dorsal root ganglion. Journal of Neurochemistry 78(Suppl 1): 195

Adler, J.E.; Skoff, A.M. 1999: NGF enhances release of substance P from adult spinal sensory neurons. Society for Neuroscience Abstracts 25(1-2): 1946

Winston, J.H.; Toma, H.; Micci, M.A.; Shenoy, M.; Pasricha, P.J. 2000: NGF expression and release in experimental and human pancreatitis and its potential role in the pathogenesis of pain in chronic pancreatitis. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A633

Dawn, K.C.I.; Ramkishen, P.N.; Armugam, A.; Jeyaseelan, K. 2003: NGF form cobra venom, promotes the expression of the endogenous NGF in PC12 cells. Journal of Neurochemistry 87(Suppl 1): 175

Tuszynski, M.H.; Conner, J.M. 2000: NGF gene delivery reverses age-related losses in cholinergic innervation of primate cortex. Experimental Neurology 164(2): 461

Romero, M.I.; Rangappa, N.; Li, L.; Lightfoot, S.; Garry, M.G.; Smith, G.M. 1999: NGF gene transfer induces extensive sprouting of sensory spinal cord afferents and hyperalgesia which can be modulated by the conditional expression of L1. Society for Neuroscience Abstracts 25(1-2): 2031

Winston, J.; Shenoy, M.; Toma, H.; Pasricha, P.J. 1999: NGF induces VR1 expression and sensitization to capsaicin in adult primary sensory neurons. Gastroenterology 116(4 Part 2): A635

Gerrard, L.; Harrison, P.T.; Dalziel, R.G.; Quinn, J.P. 2000: NGF inducible expression directed by the preprotachykinin-A promoter delivered by an adenoassociated virus vector. Regulatory Peptides 86(1-3): 65

Wang, W.; Song, J.H.; Bussiere, M.; Ross, G.M.; Riopelle, R.J.; Dow, K.E. 1999: NGF modulation of ceramide and hydrogen peroxide-induced apoptotic cell death in rat PC12 cells. Society for Neuroscience Abstracts 25(1-2): 237

Reinshagen, M.; Geerling, I.; Huff, K. 1999: NGF prohormone but not the mature NGF mediates the neuron-target interaction. Society for Neuroscience Abstracts 25(1-2): 1787

Shanahan, D.A.; Chambers, P.; Khadra, M.; Neal, D.E.; Gillespie, J.I. 1999: NGF receptor and GAP-43 expression in human detrusor smooth muscle Correlation with idiopathic detrusor instability. Journal of Physiology (Cambridge) 521P: 64P

Barber, V.S.; Griffiths, H.R. 2000: NGF reduces hydrogen peroxide and amyloid beta-induced apoptosis in PC12 cells. European Journal of Neuroscience 12(Suppl 11): 32

Klimaschewski, L.P.; Angelastro, J.M.; Eschelbach, A.; Greene, L.A. 1999: NGF regulates genes involved in ubiquitin-mediated proteolysis in rat pheochromocytoma cells. Society for Neuroscience Abstracts 25(1-2): 1272

Micera, A.; Aloe, L.; Hemo, I.; Pe'er, J.; Levi Schaffer, F. 2001: NGF role in conjunctival wound repair Conjunctival fibroblasts produce and are modulated by NGF. IOVS Investigative Ophthalmology and Visual Science 42(4): S574

Mobley, W.; Howe, C.; Delcroix, J.D.; Beattie, E. 2002: NGF signalling from endosomes. Journal of Neurochemistry 81(Suppl 1): 79

Sigala, S.; Faraoni, I.; Botticini, D.; Paez Pereda, M.; Missale, C.; Bonmassar, E.; Spano, P.F. 1999: NGF treatment induces suppression of telomerase, re-expression of KA11 and abrogation of tumorigenicity in prostate cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 40: 233

Presta, L.G.; Urfer, R.; Winslow, J.W. 2001: NGF variants. Official Gazette of the United States Patent and Trademark Office Patents 1253(4)

Marlier, L.N.J.L.; Pierucci, D.; Cicconi, S.; Bonini, P.; Micarelli, N.; Miele, F.; Ammendola, S.; Nencioni, L.; Cozzolino, F.; Lauro, R.; Borbohi, P. 1999: NGF withdrawal induces apoptosis in pancreatic beta-cells. Society for Neuroscience Abstracts 25(1-2): 1783

Huang, Y.; Hanna, M.N.; Veltri, K.; Bain, J.R.; Fahnestock, M. 1999: NGF, NT-3, CNTF and GDNF mRNA expression in rat skeletal muscle following denervation and sensory protection. Society for Neuroscience Abstracts 25(1-2): 220

Smith, M.; Hendricks, W.; Tatko, L.; Islamov, R.R.; Murashov, A.K. 2003: NGF-beta promotes differentiation of neurons from murine embryonic stem cells. FASEB Journal 17(4-5): Abstract 796

Deshmukh, M.; Johnson, E.M.Jr 1999: NGF-deprived, caspase inhibitor-saved sympathetic neurons can be rescued with NGF readdition subsequent to cytochrome c release and up to the point of loss of mitochondrial membrane potential. Society for Neuroscience Abstracts 25(1-2): 1528

Howe, C.L.; Beattie, E.C.; Mobley, W.C. 1999: NGF-induced TrkA-mediated clathrin coated vesicle formation may contribute to the generation of a signaling endosome. Society for Neuroscience Abstracts 25(1-2): 1039

Klitenick, M.A.; Lu, X.; West, S.; Borden, L.A.; Zheng, Y.; Albert, V.R. 1999: NGF-induced pain is mediated by the PN1 sodium channel. Society for Neuroscience Abstracts 25(1-2): 1945

Kraemer, R.; Nguyen, H.; Kaplan, D.; Hempstead, B. 1999: NGF-induced vascular smooth muscle cell migration requires SHC activation, but utilizes signaling pathways independent of MAP kinase. FASEB Journal 13(4 Part 1): A35

Kalisch, B.E.; Rylett, R.J. 2001: NGF-mediated enhancement of cholinergic gene expression in rat primary cultures Is nitric oxide involved at the level of AP-1 activation?. Journal of Neurochemistry 78(Suppl 1): 151

Valletta, J.S.; Wu, C.; Mobley, W.C. 1999: NGF-mediated signaling pathways in rat PC12 cells. Society for Neuroscience Abstracts 25(1-2): 509

Munn, M.; Raghu, G.; Park, S.W.; Pan, C.H.; Dayn, A. 2002: NGFR as a selectable cell surface reporter. Diamond, Rochelle A, De Maggio, Susan Springer Lab Manuals In living color: Protocols in flow cytometry and cell sorting 267-275

Burnett, J. 2001: NGIA initiatives in environmental weed management. Plant Protection Quarterly 16(3): 125-126

Kumar, S.A.; Motokawa, T. 2001: NGIWYamide Effects on and localization in the starfish, Asterina pectinifera. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 130A(4): 885

Nae, I. 2000: NGOS for environment - A constant in the equation of sustainable development. Bologa, Alexandru S Author, Charlier, Roger H Author Using today's scientific knowledge for the Black Sea area's development tomorrow : 179-181

Ringuet, S. 2004: NGOs and the international trade in wild species the case of TRAFFIC. Bulletin de la Societe Zoologique de France 129(1-2): 163-185

A.Malmborg, M. 2002: NGOs in Sweden. International Journal of Cancer Suppl (13): 140

Ruoslahti, E.; Pasqualini, R. 2001: NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same. Official Gazette of the United States Patent and Trademark Office Patents 1242(5)

Espiritu, D.J.y D.; Bernardo, A.A.; Arruda, J.A.L. 2002: NH2 or COOH-terminal cytoplasmic domain is necessary for sodium bicarbonate cotransporter activity but not for targeting to the basolateral membrane. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 62A

Wagenaar, R.A.; Crawford, H.C.; Matrisian, L.M. 2000: NH2-terminal truncated beta-catenin and mutant APC co-operate to immortalize and transform colonic epithelial cells. Clinical and Experimental Metastasis 17(9): 760

Jin, J.P.; Root, D.D. 2000: NH2-terminal variable region-based modulation of conformation and flexibility of troponin T A fluorescence spectral study. Biophysical Journal 78(1 Part 2): 365A

WangKaiYing; DaiXiaoRong; LiZhenYu; WeiBo 2010: NH3 emission factors of fattening pig buildings with different floor systems. Nongye Jixie Xuebao = Transactions Of The Chinese Society For Agricultural Machinery: 1, 163-166

Jones, H.M.; Hamilton, K.L.; Papworth, G.D.; Watkins, S.C.; Devor, D.C. 2003: NH3-terminal leucines and their role in trafficking and expression of hIK1. FASEB Journal 17(4-5): Abstract 585

Nakhoul, N.L.; Abdulnour Nakhoul, S.; Hering Smith, K.S.; Hamm, L.L. 2000: NH3/NH4+ transport in Xenopus oocytes expressing AQP1. FASEB Journal 14(4): A343

Nakhoul, N.; Abdulnour Nakhoul, S.; Hering Smith, K.; Hamm, L.L. 2000: NH3/NH4+-mediated effects on the epithelial Na+ channel expressed in oocytes. Acta Physiologica Scandinavica 170(4): A40

Lauf, P.K.; Ahmed, S.; Adragna, N.C. 2000: NH4+ inhibits K-Cl cotransport in low K sheep red blood cells. Journal of General Physiology 116(1): 20a

Kobashi, Y.; Kita, H. 1999: NH4+ reduces amplitudes of spontaneous and evoked excitatory junctional potentials by suppressing glutamate uptake into the synaptic vesicles. Zoological Science 16(Suppl ): 118

Tararthuch, A.L.; Fernandez, R.; Malnic, G. 2001: NH4+ transport in chloride-depleted C11-MDCK cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 10A

Kinclova, O.; Sychrova, H.; Banuelos, M.A.; Bleykasten Grosshans, C.; Souciet, J.L.; Potier, S. 1999: NHA1 and ENA1 genes complement each other in sodium and potassium homeostasis of S cerevisiae cells. Folia Microbiologica 44(2): 227

Cembrowski, G.S.; Chan, J.; Bamforth, F.J. 2004: NHANES 1999-2000 data used to create comprehensive health-associated adolescent reference intervals for 21 chemistry analytes measured by the Hitachi 704. Clinical Chemistry 50(6, Suppl S, Part 2): A126

Herzog, C.A.; Puumala, M.; Collins, A.J. 2002: NHANES III The distribution of hemoglobin levels related to chronic kidney disease , diabetes , and congestive heart failure. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 428A

Storm, R.; Maric, K.; Klussmann, E.; Rosenthal, W. 2000: NHE proteins involved in the long-term regulation of aquaporin-2 in primary cultured IMCD cells. Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Suppl): R36

Gazmuri, R.J.; Ayoub, I.M. 2003: NHE-1 inhibition A potential new treatment for resuscitation from cardiac arrest. Karmazyn, Morris , Reprint Author, Avkiran, Metin, Fliegel, Larry The sodium-hydrogen exchanger: From molecule to its role in disease: 291-308

Ayoub, I.M.; Kolarova, J.D.; Yi, Z.; Trivedi, A.; Lubell, D.L.; Deshmukh, H.G.; Maldonado, F.A.; Gazmuri, R.J. 2002: NHE-1 inhibition during VF prevents ischemic contracture. Circulation 106(19): II264

Myers, M.Lee 2003: NHE-1 inhibitors Potential application in cardiac surgery. Karmazyn, Morris , Reprint Author, Avkiran, Metin, Fliegel, Larry The sodium-hydrogen exchanger: From molecule to its role in disease: 279-290

Yao, H.; Douglas, R.M.; Haddad, G.G. 1999: NHE-1 null neurons have abnormally low HCO3--dependent acid extrusion mechanisms. Society for Neuroscience Abstracts 25(1-2): 2209

Capasso, Giovambattista; Rizzo, Maria; Gatti, Angela Delli; Cantone, Alessandra; De Gennaro, Chiara; Russo, Ferdinando 2002: NHE-3 gene expression is up-regulated along the proximal tubules and the thick ascending limbs oh henles loop of diabetic rats. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 478A

Lapointe, M.S.; Batlle, D. 2000: NHE-3 protein expression and activity in renal cortex from prehypertensive spontaneously hypertensive rat. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 336A

Bachmann, O.; Rossmann, H.; Wuechner, K.; Strobel, J.; Gregor, M.; Seidler, U. 2001: NHE2 is the predominant pH-regulator in murine colonic crypt cells. Gastroenterology 120(5 Suppl 1): A 700

Bachmann, O.; Rossmann, H.; Wuechner, K.; Strobel, J.; Gregor, M.; Seidler, U. 2001: NHE2 is the predominant pHi-regulator in murine colonic crypt cells. Pfluegers Archiv European Journal of Physiology 441(6 Suppl): R131

Chalumeau, C.; Defontaine, N.; Du Cheyron, D.; Kellermann, O.; Paillard, M.; Poggioli, J. 1999: NHE3 activity and trafficking in proximal tubule depends on actin cytoskeleton integrity. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 2A

Zizak, M.; Cavet, M.E.; Bayle, D.; Tse, C.M.; Hallen, S.; Sachs, G.; Donowitz, M. 2000: NHE3 contains a cleavable signal peptide followed by 11 membrane spanning domains New insights into topology. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A871

Cavet, M.E.; Park, J.; Akhter, S.; Donowitz, M. 2001: NHE3 exists in multiple plasma membrane domains in fibroblasts The detergent soluble fraction is involved in trafficking. FASEB Journal 15(5): A836

Saunders, H.; Qi, W.; Poronnik, P.; Barden, J.; Mcginn, S.; Pollock, C. 2000: NHE3 in human proximal tubule cells is specifically upregulated by high D-glucose. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 53A

Herak Kramberger, C.M.; Ljubojevic, M.; Biemesderfer, D.; Brown, D.; Sabolic, I. 2000: NHE3 is targeted to the basolateral plasma membrane in straight proximal tubule segments of colchicine-treated rats. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 51A

Janecki, A.J.; Janecki, M.; Akhter, S.; Donowitz, M. 1999: NHE3 recycles between the plasma membrane and an intracellular pool Study of trafficking in living fibroblasts using a NHE3-green fluorescent protein chimera. Gastroenterology 116(4 Part 2): A892

Utsumi, H.; Tano, K.; Tokuno, O.; Tachibana, A. 2003: NHEJ pathway plays an important role in low dose-rate effects. Journal of Radiation Research 44(4): 375-376

Khundmiri, S.J.; Ahmad, A.; Baumann, P.D.; Amin, V.; Lesousky, N.; Steploc, D.; Judith, C.; Weinman, E.J.; Lederer, E.D. 2004: NHERF-1 facilitates PTH regulation of Na-K ATPase in renal proximal tubules through PDZ-1 domain. FASEB Journal 18(4-5): Abstract 217

Weinman, E.J.; Lakkis, J.; Akom, M.; Wali, R.K.; Wade, J.B. 2002: NHERF-1, NHERF-2, PDGFR-alpha, PDGFR-beta in normal human and renal transplant rejection kidneys. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 767A

Lee, D.J.; Ma, F.C.; Fleming, L.E.; Gomez Marin, O. 2001: NHIS evaluation of mortality among US farmers and pesticide applicators. American Journal of Epidemiology 153(11 Suppl): S126

Martinez, M.; Devenport, L.; Saussy, J.; Martinez, J. 2002: Drug-associated heat stroke. Southern Medical Journal 95(8): 799-802

McCarron, D.A. 2003: NHLBI's conflict of interest: why we need the Data Quality Act. American Journal of Hypertension 16(9 Pt 1): 789-791

Friedman, B.; Hersh, L.T.; Medero, R. 2000: NIBP trigger in response to detected heart rate variability. Official Gazette of the United States Patent and Trademark Office Patents 1233(3)

Modre, R.; Tilg, B.; Fischer, G.; Hanser, F.; Messnarz, B.; Seger, M.; Hintringer, F.; Roithinger, F.X. 2003: NICE Non-invasive imaging of cardiac electrophysiology. European Heart Journal 24(Abstract Suppl): 512

Rawlins, M.D. 2000: NICE the National Institute for Clinical Excellence. British Journal of Cancer 83(Suppl 1): 3

Ehrenkranz, R.A.; Wright, L.L. 2003: NICHD neonatal research network: contributions and future challenges. Seminars in Perinatology 27(4): 264-280

Parrott, E.C. 2002: NICHD training and research initiatives in reproductive science. Biology of Reproduction 66(Suppl 1): 74

Gray, J.; Goldmann, D.; Ursprung, R.; Edwards, W.; Plesk, P.; Shiono, P.; Suresh, G.; Horbar, J. 2003: NICU Clinical Decision Support Systems The need for population-specific critical lab result definitions. Pediatric Research 53(4 Part 2): 381A

Spitzer, A.R.; Kornahuser, M.; Kirkby, S.; Musci, M. 2002: NICU decision-making The effect of nursery structure on achievement of milestones in the NICU and cost of care. Pediatric Research 51(4 Part 2): 374A

Koravangatu, S.; Seshia, M.; Walker, R.; Ohlsson, A.; Lee, S.K. 2000: NICU mortality in a large population based Canadian cohort. Pediatric Research 47(4 Part 2): 315A

Angeles, D.M.; Oberg, K.; Sheridan, F.; Pearce, W.J. 2003: NICU pharmacotherapy alters neonatal cerebrovascular reactivity. FASEB Journal 17(4-5): Abstract 573

Rivera, M.; Gonzalez, J.; Garcia, L.; Garcia, I.; Valcarcel, M. 1999: NICU survivors parents A satisfaction study in Puerto Rico. Pediatrics 104(3 Part 3): 754

Chefer, S.I.; Pavlova, O.A.; Zhang, Y.; Vaupel, D.B.; Kimes, A.S.; Kurian, V.; Horti, A.G.; Mukhin, A.G. 2003: NIDA52189 and NIDA522131 Promising new radioligands for imaging extrathalamic high affinity nicotinic receptors with PET. Journal of Labelled Compounds and Radiopharmaceuticals 46(Suppl 1): S63

Barocci, S.; Miotti, V.; Fiordoro, S.; Lorenzi, S.; Barocci, F.; Centore, C.; Ribizzi, G.; De Pascale, A. 2001: NIDDM and DQ genes No association in families with a high disease incidence. European Journal of Immunogenetics 28(2): 312

Mathews, C.E.; Bagley, R.; Caldwell, J.; Leiter, E.H. 2001: NIDDM in a new mouse model elicited by low free radical scavenging potential combined with behavioral and dietary stress. Diabetes 50(Suppl 2): A517

Yonei, T.; Akiyama, K.; Ikeda, N.; Fukuda, T.; Tsuji, T. 2000: NIDDM with hyperglycemia, high ACTH and high ADH during frequent onsets of vomiting and fever of unknown etiology in an adult. Journal of the Japan Diabetes Society 43(3): 221-224

Newman, D.L.; Tsalenko, A.; Cox, N.J.; Ober, C. 1999: NIDDM1 is associated with diabetes and body fat distribution in the Hutterites. American Journal of Human Genetics 65(4): A437

Bonaventura, C. 1999: NIEHS workshop: unique marine/freshwater models for environmental health research. Environmental Health Perspectives 107(1): 89-92

Preusch, P.C. 2001: NIH Metals in Medicine initiative. Abstracts of Papers American Chemical Society 222(1-2): INOR190

Bae, C.J.; Andrefsky, J.C.; Mascha, E.J.; Degeorgia, M.A. 2001: NIH Stroke Scale with ICH volume predicts three-month mortality and functional outcome. Neurology 56(8 Suppl 3): A78-A79

Alving, B. 2004: NIH asks participants in Women's Health Initiative estrogen-alone study to stop study pills, begin follow-up phase. Southern Medical Journal 97(4): 425-426

Gillette, M.U.; Roth, T.; Kiley, J.P. 1999: NIH funding of sleep research: a prospective and retrospective view. Sleep 22(7): 956-958

Li, A. 2004: NIH pumps money into biodefence. Drug Discovery Today 9(13): 547

Malenka, R. 2002: NIH workshop report: taming the brain's complexity. Neuron 36(1): 29-30

Barisoni, L.; Arend, L.; Bonsib, S.; Cohen, A.; Haas, M.; Stillman, I.; Walker, P.; Kessing, B.; Kopp, J. 2003: NIH/NYU podocyte disease registry. Journal of the American Society of Nephrology 14(Abstracts Issue): 151A

Fagarasan, S.; Shinkura, R.; Kamata, T.; Nogaki, F.; Ikuta, K.; Tashiro, K.; Honjo, T. 2000: NIK mutation causes defects in SLC receptor signaling and homing of peritoneal cells to the GALT system. Scandinavian Journal of Immunology 51(Suppl 1): 47

Hu, W.H.; Walters, W.; White, M.; Dietrich, W.D.; Bethea, J.R. 2001: NIK-associated protein , a negative regulator of TNF signaling. FASEB Journal 15(5): A1040

Hunter, T.; Lu, K.P.ng 1999: NIMA interacting proteins. Official Gazette of the United States Patent and Trademark Office Patents 1226(2)

Pequegnat, W.; Fishbein, M.; Celentano, D.; Ehrhardt, A.; Garnett, G.; Holtgrave, D.; Jaccard, J.; Schachter, J.; Zenilman, J. 2000: NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sexually Transmitted Diseases 27(3): 127-132

Horner, R.D. 2002: NINDS A partner in Arctic health research. Arctic Science Conference Abstracts 53: 116

Key, M.M.; Robbins, A.; Millar, J.D.J.; Rosenstock, L. 2004: NIOSH and the CDC reorganization. Science 305(5684): 607

Schaitberger, H.A. 2004: NIOSH's work on firefighting. Science 305(5684): 607

Matsuda, T.; Masumiya, H.; Saito, T.; Tanaka, H.; Shigenobu, K.; Yamashita, T.; Tsuruzoe, N. 1999: NIP-142, a novel benzopyran derivative Electrophysiological study on the mechanisms of bradycardiac effects. Japanese Journal of Pharmacology 79(Suppl 1): 178P

Bassermann, F.C.; Kluempen, S.; Von Klitzing, C.; Bai, R.Y.; Ouyang, T.; Morris, S.W.; Peschel, C.; Duyster, J. 2003: NIPA couples SCF-based ubiquitination to the regulation of mitosis. Blood 102(11): 168a

Egidio,V.di; Sinelli,N.; Giovanelli,G.; Moles,A.; Casiraghi,E. 2010: NIR and MIR spectroscopy as rapid methods to monitor red wine fermentation. European Food Research And Technology 2010(6): 947-955

Barbour, R.L. 2000: NIR clinical opti-scan system. Official Gazette of the United States Patent and Trademark Office Patents 1235(4)

Wilson, N. 2003: NIR methods of detecting counterfeit products. Journal of Pharmacy and Pharmacology 55(Suppl): S 98

Cremonesi, Alberto; Alberti, Alessandro; Castriota, Fausto; Ricci, Enrico; El Jamal, Bilal; Grattoni, Chiara; Manetti, Raffaella; Nannini, Cristina; Filippini, Claudia 1999: NIR stenting registry Retrospective observation on immediate results and clinical follow-up in 709 patients. European Heart Journal 20(ABSTR Suppl ): 157

Aubard, J.; Levi, G.; Rutherford, T.; Keene, R.; Kirsch, D.M.smaeker, A. 1999: NIR-FT Raman spectroscopy of the stereoisomers of a dinuclear Ru-HAT complex, photoprobe of denatured DNA. Greve, J, Pupels, G J, Otto, C Spectroscopy of biological molecules: New directions 249-250

Tommasi, S.; Abatangelo, M.; Lacalamita, R.; Marzullo, F.; Montemurro, S.; Paradiso, A. 2000: NIRCA analyses for TP53 mutations in human colon cancer. International Journal of Biological Markers 15(3): 256

Shenderey,C.; Shmulevich,I.; Alchanatis,V.; Egozi,H.; Hoffman,A.; Ostrovsky,V.; Lurie,S.; Arie,R.B.; Schmilovitch,Z. 2010: NIRS detection of moldy core in apples. Food And Bioprocess Technology: 1, 79-86

Ksiksi, T.; Ash, A.; Fry, P.; Allen, P. 2000: NIRS predicts seasonal changes in diet quality of cattle. Tropical Grasslands 34(3-4): 306

Schuchardt, K.; Neumann, S.; Reske, A.; Paschke, R. 2001: NIS expression in cold thyroid nodules. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S39

Saito, T.; Endo, T.; Onaya, T. 2000: NIS expressions in thyroid diseases. Endocrine Journal 47(Suppl August): 81

Xiao, Y.; Welch, M.; Semmes, O.J.; Barker, P.E. 2002: NIST SRM 1951a as a prototype serum standard for human proteomics. Molecular and Cellular Proteomics 1(9): 691

Yang, T.; Figallo, L.; Chambers, W.H. 2004: NK CellDC Interactions Enhance Lytic Function Against YAC-1 But Not Against Glioma Tumor Targets. FASEB Journal 18(4-5): Abstract 775

Sharifi, G.R.; Kinnon, C.; Thrasher, A.; Gaspar, B.H. 2002: NK Cells as New Target for Gene Therapy; Using Retroviral Vectors as Promising Delivery System. Blood 100(11): Abstract No. 2559

Vance, B.A.; Schenk, A.S.; Erdmann, A.; Fowler, D.; Gress, R.E. 2002: NK Receptor Diversity Analysis of Freshly Isolated and Cultured Lymphocytes. Blood 100(11): Abstract No. 3672

Campos, R.A.; Szczepanik, M.; Iliopoulou, P.; Akahira Azuma, M.; Askenase, P.W.lliam 2001: NK T cell-derived IL-4 activates B-1 cells to initiate contact sensitivity. FASEB Journal 15(4): A693

Bach, J.F.; Herbelin, A.; Lehuen, A.; Carnaud, C. 1999: NK T cells and autoimmunity. Immunology 98(Suppl 1): 32

Kumar, V.; Maricic, I.; Jahng, A. 2003: NK T cells specific for a myelin-derived glycolipid, cerebroside sulfate prevent autoimmune demyelination. FASEB Journal 17(4-5): Abstract 207

Kishi, A.; Ohmori, M.; Tomita, S.; Niman, M.; Uno, K.; Tanigawa, M.; Setoguchi, J.; Nita, H.; Ikeda, T.; Kishida, T.; Fujita, S. 1999: NK activity and IFN-gamma release in cancer patients. Journal of Interferon and Cytokine Research 19(Suppl 1): S141

Sirova, M.; Rossmann, P.; Jelinkova, M.; Kovar, M.; Ulbrich, K.; Rihova, B. 2000: NK activity in tumor-bearing mice treated with doxorubicin and HPMA-bound doxorubicin. Immunology Letters 73(2-3): 181

Denis, L.; Gagne, K.; Gueglio, B.; Simon, P.; Cesbron, A.; Milpied, N.; Bonneville, M.; Follea, G.; Harrousseau, J.L.; Bignon, J.D. 2003: NK and CD8 T cells immune reconstitution and KIR gene transcripts in allogeneic bone marrow transplantation. Genes and Immunity 4(Suppl 1): S23

Matsuo, Y.; Drexler, H.G.; Harashima, A.; Okochi, A.; Orita, K. 2003: NK and NKT cell leukemia-lymphoma cell lines Expression profiles of transcription factors. Proceedings of the American Association for Cancer Research Annual Meeting 44: 499

Muehlen, K.A.; Schuemann, J.; Wittke, F.; Stenger, S.; Van Kaer, L.; Tiegs, G. 2003: NK and NKT cells in Pseudomonas aeruginosa Exotoxin A Induced hepatotoxicity in mice. Journal of Hepatology 38(Suppl 2): 208

Lukassen, H.G.M.; Van Der Meer, A.; Lindeman, E.; Wetzels, A.; Wijnands, F.; Van Lierop, M.J.C.; Mosselman, S.; Joosten, I.; Braat, D.D.M. 2000: NK and T cell subpopulations in follicular fluid in relation to the cause of infertility. Immunobiology 203(1-2): 549-550

Ishimaru, H.; IIno, S. 2000: NK and T cells positive for Fas antigen in peripheral blood of patients with hepatocellular carcinoma. Journal of Hepatology 32(Suppl 2): 167

Miles, M.P.; Mackinnon, L.T.; Williams, N.I.; Bush, J.A.; Marx, J.O.; Mastro, A.M.; Kraemer, W.J. 1999: NK cell activity and LFA-2 expression after running. Medicine and Science in Sports and Exercise 31(5 Suppl): S240

Ruggeri, L.; Perruccio, K.; Montagnoli, C.; Romani, L.; Velardi, A. 2003: NK cell conditioning to mismatched BMT confers immediate responsiveness to infectious challenges. Blood 102(11): 698a

Doshi, D.R.; Lu, E.; Ballas, Z.K. 2004: NK cell dysfunction and hypogammaglobulinemia in a patient presenting with invasive rhinocerebral mucormycosis. Journal of Allergy and Clinical Immunology 113(2 Suppl): S128

Carter, D.L.; Shieh, T.M.; Blosser, R.L.; Chadwick, K.R.; Margolick, J.B.; Hildreth, J.E.K.; Clements, J.E.; Zink, M.C. 1999: NK cell idedntification using cytometric analysis, flow cytometric cell sorting, and functional analysis in rhesus macaques. FASEB Journal 13(5 Part 2): A960

Vyas, Y.; Mehta, K.; Morgan, M.; Butros, L.; Selvakumar, A.; Burkhardt, J.; Dupont, B. 2000: NK cell immune synapse in cytolytic and non-cytolytic interactions. FASEB Journal 14(6): A1024

Miller, J.S.; Xiao, F.; Mccullar, V.; Dewaard, R.; Weisdorf, D.J. 2003: NK cell killer immunoglobulin receptor reconstitution is diminished in recipients of unrelated donor transplants who receive unmanipulated marrow grafts. Blood 102(11): 726a

Navarro, F.; Llano, M.; García, P.; López-Botet, M. 1999: NK cell mediated recognition of HLA class Ib molecules: role of CD94/NKG2 receptors. Journal of Reproductive Immunology 43(2): 167-173

Regunathan, J.; Zhang, M.; Milisauskas, V.; Nakamura, I. 2000: NK cell reactivity against MHC-identical allogeneic lymphoblast targets. FASEB Journal 14(6): A1020

Moser, J.M.; Byers, A.M.; Lukacher, A.E. 2002: NK cell receptors in antiviral immunity. Current Opinion in Immunology 14(4): 509-516

E.S.erbiny, Y.M.; Davies, F.E.; Cook, G.; Johnson, R.J.; Cullen, M.J.; Sah, A.; Rawstron, A.C.; Richards, S.J.; Morgan, G.J. 2003: NK cell repertoire in myeloma and the impact of thalidomide. Blood 102(11): 443a

Christmas, S.E.; Morris, J.; Croker, S. 2001: NK cell surface molecule expression by human decidualized endometrial leucocytes. American Journal of Reproductive Immunology 46(1): 39-40

Borg, C.; Taieb, J.; Terme, M.; Maruyama, K.; Flament, C.; Angevin, E.; Zitvogel, L. 2003: NK cell-based immunotherapy: new prospects and involvement of dendritic cells. Bulletin du Cancer 90(8-9): 699-705

IIjima, K.; Kobayashi, T.; Kita, H. 2003: NK cell-dependent, airway-specific, innate eosinophilic response to Alternaria in mice. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S199

Suzuki, K.; Nakazato, H.; Hasumi, M.; Matsui, H.; Ito, K.; Fukabori, Y.; Kurokawa, K.; Yamanaka, H. 2001: NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3 Immunogene therapy utilizing a highly secretable form of interleukin-15 gene transfer. Journal of Urology 165(5 Suppl): 140

Akiba, H.; Motoki, Y.; Satoh, M.; Oyama, N.; Tojo, M.; Iwatsuki, K.; Kaneko, F. 2000: NK cell-mediated innate immunity rather than adaptive cell-mediated immunity is important in elimination of deep fungal infection. Journal of Dermatological Science 23(3): 209

Park, H.J.; Yoon, J.; Ryu, H.; Kim, J.; Kim, S.J. 2001: NK cell-mediated killing toward thyroid carcinomas. FASEB Journal 15(4): A660

Scott-Algara, D.; Paul, P. 2002: NK cells and HIV infection: lessons from other viruses. Current Molecular Medicine 2(8): 757-768

Biron, C.A.; Brossay, L. 2001: NK cells and NKT cells in innate defense against viral infections. Current Opinion in Immunology 13(4): 458-464

Chen, D.; Cao, R.H.; Guo, H.; Chen, G.; Wang, X.M.; Shen, S.Q.; Chen, S. 2003: NK cells and macrophages play a pivotal role in delayed xenograft rejection of pig-to-rhesus monkey cardiac transplantations after a high activity Y-CVF therapy. Xenotransplantation 10(5): 495

Itescu, S. 2001: NK cells and monocytes in xenograft rejection Role of porcine carbohydrate antigens. Xenotransplantation 8(Suppl 1): 55

Brandau, S.; Riemensberger, J.; Jacobsen, M.; Kemp, D.; Zhao, W.; Zhao, X.; Flad, H.D.; Ratliff, T.L.; Boehle, A. 2000: NK cells are essential for effective immunotherapy of bladder cancer with Mycobacterium bovis BCG. Immunobiology 203(1-2): 399

Brandau, S.; Riemensberger, J.; Kemp, D.; Jocham, D.; Boehle, A. 2000: NK cells as mediators of BCG-immunotherapy Evidence from in vitro and in vivo studies. European Urology 37(Suppl 2): 50

Carbone, E.; Terrazzano, G.; Melian, A.; Zanzi, D.; Moretta, L.; Porcelli, S.; Karre, K.; Zappacosta, S. 1999: NK cells can recognize classical and non-classical MHC class I molecules. Journal of Leukocyte Biology (Suppl ): 11

Briard, Diane; Azzarone, Bruno; Le Bousse Kerdiles, Caroline; Jasmin, Claude; Brouty Boye, Daniele 2001: NK cells generated from peripheral blood CD34 stem cells in coculture with fibroblasts from normal and myelometaplasic human spleen tissue. Proceedings of the American Association for Cancer Research Annual Meeting 42: 332

Horvath Arcidiacono, J.A.; Bloom, E.T. 1999: NK cells in the human anti-pig response Response to cytokines. FASEB Journal 13(5 Part 2): A963

Xu, Q.; Goleva, E.; Leung, D.Y.M. 2004: NK cells induce corticosteroid unresponsiveness in B-cells treated with IL-15. Journal of Allergy and Clinical Immunology 113(2 Suppl): S214

Swanborg, R.H.; Wolf, N.A. 2000: NK cells maintain immune homeostasis. FASEB Journal 14(4): A700

D.S.ntis, D.; Bishara, A.; Nagler, A.; Witt, C.S.; Slavin, S.; Brautbar, C.; Christiansen, F.T. 2004: NK epitope matching and KIR genotype influence outcome in unrelated hematopoietic stem cell transplantation. Genes and Immunity 5(Suppl 1): S3

Wei, S.; Gilvary, D.L.; Corliss, B.C.; Sebti, S.; Sun, J.; Straus, D.B.; Leibson, P.J.; Weber, M.J.; Djeu, J.Y. 2000: NK lysis of tumor cells Requirement for a Ras-independent MAPK signal pathway. Proceedings of the American Association for Cancer Research Annual Meeting 41: 620

Christiansen, Frank T.; Gaudieri, Silvana; De Santis, Dianne; Moore, Corey B.; Witt, Campbell S.; James, Ian R.; Mallal, Simon A. 2003: NK receptor genes are predictors of HIV progression. Human Immunology 64(Suppl 1): S12

Kitoh, T.; Shibata, M.; Sawada, M.; Nakayama, H.; Ishii, E.; Hyakuna, N.; Nakahata, T.; Schuster, S.M. 2001: NK related antigen positive leukemia with low expression of asparagine synthetase; a group of leukemia clinically sensitive to L-asparaginase. Experimental Hematology 29(8 Suppl 1): 25

Kramer, M. 2000: NK-1 antagonists as antidepressants Clinical studies. European Neuropsychopharmacology 10(Suppl 3): S122-S123

Stacey, A.E.; Jones, R.S.G. 2000: NK-1 receptor activation enhances GABA release in the rat entorhinal cortex in vitro. European Journal of Neuroscience 12(Suppl 11): 366

Hoffmann, T.; Poli, S.M.; Schnider, P.; Sleight, A. 2003: NK-1 receptor active amine oxide prodrugs. Official Gazette of the United States Patent and Trademark Office Patents 1272(3)

Piedimonte, G.; Hess, H.J.; Lowe, J.A.I.i 2003: NK-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy. Official Gazette of the United States Patent and Trademark Office Patents 1270(2)

Howard, Harry Ralph 1999: NK-1 receptor antagonists for the treatment of cancer. Official Gazette of the United States Patent and Trademark Office Patents 1228(4)

Nelson, R.B.; Lowe, J.A.IIi 2002: NK-1 receptor antagonists for the treatment of neuronal injury and stroke. Official Gazette of the United States Patent and Trademark Office Patents 1257(4)

Lima, D.; Tavares, I. 2000: NK-1 receptor immunoreactivity is differentially expressed in lamina I spinal neurons projecting to the caudal ventrolateral medullary reticular formation. European Journal of Neuroscience 12(Suppl 11): 483

Renzi, D.; Pellegrini, B.; Tonelli, F.; Surrenti, C.; Calabro, A. 2000: NK-1R and NK-2R gene and protein expression in Crohns disease and ulcerative colitis. Digestive and Liver Disease 32(Suppl 1): A8

Doggrell, S.A.; Castaner, J. 2003: NK-3201 Treatment of restenosis, treatment of myocardial infarction, chimase inhibitor. Drugs of the Future 28(4): 323-327

Suzuki, M.; Tanabe, F.; Nakamura, S.; Motoda, R.; Orita, K. 2004: NK-355, an aminovinyl photosensitizing dye, enhances collagen production through TGF-beta1 upregulation. Journal of Dermatological Science 34(1): 56-58

Kukreja, A.; Costi, G.; Zhang, C.H.; Marker, J.; Sanz, M.; Lin Su, K.; Ten, S.; Sun, Z.; Maclaren, N.K. 2001: NK-T cell deficiency in autoimmune diseases A diagnostic/predictive test for immune mediated diabetes. Diabetes 50(Suppl 2): A78

Rhee, R.J.; Carlton, S.; Chung, C.S.; Lomas, J.L.; Lane, C.; Ayala, A. 2002: NK-T cells as potential contributors to the immune dysfunction seen in sepsis. FASEB Journal 16(5): A1228

Lee, H.R.; Lee, H.; Kim, S.W.; Baek, S.Y.; Kim, W.S.; Yoon, S.S.; Im, Y.H.; Kang, W.K.; Park, K.; Park, C.H.; Lee, M.H. 2001: NK-cell activity and T4/T8 ratio in patients with autologous graft-versus-host disease induced by cyclosporine and gamma-interferon. Experimental Hematology 29(8 Suppl 1): 93

Sapak, M.; Lindemann, M.; Kreuzfelder, E.; Buc, M.; Beelen, D.W.; Grosse Wilde, H. 2003: NK-cell cytotoxicity and leukocyte subpopulations after allogeneic hematopoietic cell transplantation. Genes and Immunity 4(Suppl 1): S49

Vossen, M.T.M.; Baars, P.A.; Van Lier, R.A.W.; Kuijpers, T.W. 2000: NK-cell deficiency in a child with fatal varicella zoster virus infection. Immunobiology 203(1-2): 473-474

Wanka, H.; Kloeting, I.; Kuttler, B. 2001: NK-cells and macrophages influence T-helper lymphocyte mediated beta-cell destruction in BB rats. Diabetologia 44(Suppl 1): A 150

Pieper, G.M.; Olds, C.; Bub, J.; Lindholm, P.F. 2000: NK-kappaB activation and increased kappaB-dependent transactivation in human endothelial cells by HIV-1 Tat protein. Journal of Submicroscopic Cytology and Pathology 32(3): 477

Drumm, K.; Gekle, M. 2003: NK-kappaB and proteinuric renal disease. Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents 2(1): 29-36

Ziske, C.G.; Maerten, A.; Sauerbruch, T.; Schmidt Wolf, I.G. 2000: NK-like T-lymphocytes and dendritic cells pulsed with pancreatic cancer tumor cell lines derived RNA are effective to induce cytolytic activity against pancreatic cancer. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A528

Gaal, K.; Sun, N.C.J.; Hernandez, A.M.; Arber, D.A. 2000: NK/T cell sinonasal lymphomas in the United States. Laboratory Investigation 80(3): 149A

Ko, Y.H.; Ree, H.J. 1999: NK/T-cell lymphomas The lineage and comparative genomic hybridization study. Virchows Archiv 435(3): 263

Calabro, A.; Renzi, D.; Pellegrini, B.; Savini, L.; Tonelli, F.; Surrenti, C. 1999: NK1 and NK2 receptor gene and protein expression in inflammatory bowel disease. Gastroenterology 116(4 Part 2): A676

Baroni, S.; Masala, I.; Giusti, L.; Betti, L.; Giannaccini, G.; Marazziti, D. 2003: NK1 receptors in human blood lymphocytes and granulocytes. European Neuropsychopharmacology 13(Suppl 4): S269

Mechiche, H.; Koroglu, A.; Birembaut, P.; Elaerts, J.; Devillier, P. 2000: NK1-receptor mediated relaxation of human pulmonary vessels is endothelium-dependent and subjected to rapid desensitization. Fundamental and Clinical Pharmacology 14(3): 273

Han, J.; Zhou, X.; Markle, R.A.; Summer, B.; Yokoyama, T.; Nicholson, A.C.; Gotto, A.M.Jr; Hajjar, D.P. 2002: NK104 inhibits expression of tissue factor by monocytes and CD36 by macrophages. FASEB Journal 16(4): A209

Moodycliffe, A.M.; Ullrich, S.E. 1999: NK11+CD4+ T cells suppress immunity against ultraviolet-B radiation -induced skin tumors. Photochemistry and Photobiology 69(SPEC ISSUE ): 97S

Bailey, C.P.; Jones, R.S.G. 1999: NK2-receptor activation increases spontaneous GABA-release in the rat nucleus tractatus solitarius in vitro. British Journal of Pharmacology 127(Proceedings Suppl ): 48P

Sanger, G.J.; Alex, G.; Shafton, A.D.; Furness, J.B. 2002: NK3 receptor antagonism by talnetant suggests a role for NK3 receptors in enteric reflexes evoked by relatively intense stimuli. Gastroenterology 122(4 Suppl 1): A-256

Kubota, T.S.; Fujiwara, H.; Amaike, H.; Takashima, K.; Inada, S.; Atsuji, K.; Yoshimura, M.; Matsumoto, K.; Nakamura, T.; Yamagishi, H. 2003: NK4 expression by CT26 colon cancer cells inhibits their malignant phenotype and induces potent antitumor effect. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1095-1096

Martin, T.A.; Matsumoto, K.; Nakamura, T.; Mansel, R.E.; Jiang, W.G. 2000: NK4, a HGF/SF antagonist, inhibits breast cancer cell invasion of endothelium Its role in HGF/SF induced changes of tight junction function. Breast Cancer Research and Treatment 64(1): 110

Martin, T.A.; Jiang, W.G.; Mansel, R.E. 2001: NK4, an HGF/SF antagonist inhibits HGF/SF induced changes in tight junction proteins. British Journal of Cancer 85(Suppl 1): 84

Matsumoto, T.; IIda, M.; Ishida, K.; Sakitama, K.; Nishikawa, K. 2001: NK5807, a novel non-peptide antagonist of tachykinin NK2 receptor. Japanese Journal of Pharmacology 85(Suppl 1): 200P

Sellers, D.; Hay, D.; Chess Williams, R.; Chapple, C. 2003: NKA responses in normal versus idiopathic and neurogenic overactive human detrusor muscle. European Urology Suppls 2(1): 170

Marietta, E.V.; Trejo, T.; Smart, M.; Rajagopalan, G.; David, C. 2002: NKB1 inhibits NK cells and CD8+ T cells, but not CD4+ T cells in NKB1/HLA-B27 transgenic mice. FASEB Journal 16(5): A1057

Wall, S.M.; Mehta, P.; Hassell, K.; Park, S.J. 1999: NKCC1 mediates Cl- secretion in rat outer medullary collecting duct, inner stripe. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 47A-48A

Hue, S.; Berrih Haknin, S.; Caillat Zucman, S. 2002: NKG2D and MICA expression in the thymus. European Journal of Immunogenetics 29(2): 130

Mrowka, P.; Golab, J. 2004: NKG2D receptor and its ligands. Postepy Biologii Komorki 31(1): 71-80

Cerwenka, A.; Lanier, L.L. 2001: NKG2D/DAP10 An immune receptor for oncofetal antigens. FASEB Journal 15(4): A660, Ch 7

Morikawa, M.; Nakashima, S.; Komatsu, K.; Abe, T. 2001: NKH477, a forskolin derivative, exerts an antiproliferative effect in vivo with an altered cytokine profile in rat recipients of orthotopic lung allografts. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 20(2): 254

Iwatsubo, K.; Tao, Y.; Onda, T.; Toya, Y.; Fujita, T.; Umemura, S.; Ishikawa, Y. 2001: NKH477, a new inotropic reagent that directly stimulates adenylyl cyclase, does not cause the beta-adrenergic receptor downregulation; demonstration using a newly developed whole cell binding assays. Journal of the American College of Cardiology 37(2 Suppl A): 272A

Jourdan, K.B.; Long, L.; Morrell, N.W. 2000: NKH477, an adenylyl cyclase type 5 selective forskolin derivative, inhibits pulmonary artery smooth muscle cell proliferation. Thorax 55(Suppl 3): A34

Kornbluth, J.; Portis, T.; Esposito, A.; Grigoriev, V. 1999: NKLAM A novel granule-associated membrane protein involved in NK and T cell-mediated cytotoxicity. FASEB Journal 13(5 Part 2): A965

Kent, S.; Strominger, J.L.; Hafler, D.A.; Wilson, S.B. 1999: NKR-P1A+ T cells with noncanonical T cell receptor alpha chains respond to CD1d. FASEB Journal 13(4 Part 1): A628

Taniguchi, M.; Kawano, T.; Koezuka, Y. 2003: NKT cell activators containing alpha-glycosylceramides. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)

Sonoda, K.H.; Faunce, D.; Taniguchi, M.; Stein Streilein, J. 2000: NKT cell derived IL-10 is required for induction of ACAID. IOVS Investigative Ophthalmology and Visual Science 41(4): S116

Oikawa, Y.; Shimada, A.; Yamada, S.; Motohashi, Y.; Nakagawa, Y.; Irie, J.-I.; Maruyama, T.; Saruta, T. 2003: NKT cell frequency in Japanese type 1 diabetes. Annals of the new York Academy of Sciences 1005: 230-232

Saikh, K.U.; Dyas, B.; Kissner, T.L.; Ulrich, R.G. 2001: NKT cell recognition of MHC class II ligands. FASEB Journal 15(5): A1021

Pejnovic, N.; Groves, R.; Mee, J.; Chan, W. 2003: NKT cell subsets in the peripheral circulation of patients with psoriasis. Journal of Investigative Dermatology 121(1): 1010

Taniguchi, M.; Kawano, T.; Koezuka, Y. 2004: NKT cell-activating agents containing alpha-glycosylceramides. Official Gazette of the United States Patent and Trademark Office Patents 1283(2)

Hong, C.; Sung, R.H.; Park, S.H. 2003: NKT cell-dependent adjuvant effect of alpha-galactosyl ceramide in tumor rejection. FASEB Journal 17(7): C330

Campos, R.A.; Szczepanik, M.; Itakura, A.; Kronenberg, M.; Askenase, P.W. 2003: NKT cell-derived IL-4 is required early in allergic contact sensitivity. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S272

Yamamura, T.; Miyamoto, K.; Illés, Z.; Pál, E.; Araki, M.; Miyake, S. 2004: NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease. Current Topics in Medicinal Chemistry 4(5): 561-567

Godfrey, D.I.; Hammond, K.J.; Poulton, L.D.; Smyth, M.J.; Baxter, A.G. 2000: NKT cells: facts, functions and fallacies. Immunology Today 21(11): 573-583

Sonoda, K.H.; Exley, M.; Balk, S.; Stein Streilein, J. 1999: NKT cells are required for induction of CD8+ suppressor T cells in ACAID. IOVS Investigative Ophthalmology and Visual Science 40(4): S860

Hayglass, K.T.; Haile, S. 2003: NKT cells can exacerbate ongoing type 2 immunity in an antigen-specific manner. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S316

Fujita, K.; Kobayashi, M.; Herndon, D.N.; Roberts, N.J.J.; Suzuki, F. 2003: NKT cells lacking IL-4 producing abilities stimulate naive T cells to generate Th2 cells. FASEB Journal 17(7): C143

Dalle, J.H.; Menezes, J.; Wagner, E.; Champagne, M.A.; Blagdon, M.; Duval, M. 2003: NKT cells ontogeny Phenotypic analysis of human cord blood and adult peripheral NKT cells. Blood 102(11): 398b

Shibolet, O.; Alper, R.; Zolotarov, L.; Thalenfeld, B.; Engelhardt, D.; Rabbani, E.; Ilan, Y. 2002: NKT lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigens pulsed dendritic cells. Hepatology 36(4 Part 2): 386A

German, M.S.; Rubenstein, J.L.R.; Sussel, L.; Sander, M.; Hartigan O'connor, D.J.; Pedersen, R.A.; Meneses, J.J. 2000: NKX-22 and NKX-61 transgenic mouse models for diabetes, depression, and obesity. Official Gazette of the United States Patent and Trademark Office Patents 1239(1)

Jakowlew, S.B.; Kang, Y. 2003: NKX21 transcription factor reduction in adenocarcinomas in a transforming growth factor-B1 heterozygous mouse model of lung carcinogenesis and regulation of NKX21 by TGF-B1 occurs through TGF-B Type II receptor, smads 2/3/4, Sp1, and Sp3 in mouse lung cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 875

Mcelhinney, D.B.; Geiger, E.; Blinder, J.; Benson, D.W.; Goldmuntz, E. 2002: NKX25 mutations in patients with congenital heart disease. Circulation 106(19): II166-II167

Asatiani, E.; Minta Lucci, D.; Bowen, C.; Rodriguez, E.; Gelmann, E. 2003: NKX31 is a haploinsufficient tumor suppressor for human prostate cancer that regulates expression of vascular endothelial growth factor. Proceedings of the American Association for Cancer Research Annual Meeting 44: 594

Goddard, A.; Godowski, P.J.; Gurney, A.L. 2002: NL2 TIE ligand homologue polypeptide. Official Gazette of the United States Patent and Trademark Office Patents 1262(4)

Goddard, A.; Godowski, P.J.; Gurney, A.L. 2003: NL3 TIE ligand homologue. Official Gazette of the United States Patent and Trademark Office Patents 1267(3)

Goddard, A.; Godowski, P.J.; Gurney, A.L. 2002: NL3 TIE ligand homologue nucleic acids. Official Gazette of the United States Patent and Trademark Office Patents 1260(5)

Godowski, P.J.; Gurney, A.L.; Hillan, K.; Botstein, D.; Goddard, A.; Roy, M.; Ferrara, N.; Tumas, D.; Schwall, R. 2003: NL4 tie ligand homologue. Official Gazette of the United States Patent and Trademark Office Patents 1269(4)

Godowski, P.; Gurney, A.; Hillan, K.J.; Botstein, D.; Goddard, A.; Roy, M.; Ferrara, N.; Tumas, D.; Schwall, R. 2002: NL4 tie ligand homologue nucleic acid. Official Gazette of the United States Patent and Trademark Office Patents 1260(1)

Godowski, P.J.; Gurney, A.L. 2002: NL8 tie ligands homologues. Official Gazette of the United States Patent and Trademark Office Patents 1265(2)

Nandabalan, K.; Schulz, V.P.; Yang, M. 2002: NLK1 protein and NLK1 protein complexes. Official Gazette of the United States Patent and Trademark Office Patents 1264(1)

Wang, J.F.; Chen, B.; Young, L.T. 1999: NLRG, a similar protein of nitrogen permease regulator was increased by lithium in rat brain. Society for Neuroscience Abstracts 25(1-2): 1066

Escriou, V.; Carrière, M.; Scherman, D.; Wils, P. 2003: NLS bioconjugates for targeting therapeutic genes to the nucleus. Advanced Drug Delivery Reviews 55(2): 295-306

Chin, R.F.M.; Neville, B.G.R.; Bedford, H.; Wade, A.; Peckham, C.; Scott, R.C. 2003: NLSTEPSS A population-based study on convulsive status epilepticus in childhood. Epilepsia 44(Suppl 9): 163

Orringer, J.; Kang, S.; Cho, S.; Schumacher, W.; Karimipour, D.; Voorhees, J.J. 2004: NLite pulsed dye laser therapy for acne vulgaris a randomized clinical trial. Journal of Investigative Dermatology 122(3): A51

Standring, D.N.; Lanford, R.; Wright, T.; Chung, R.T.; Bichko, V.; Cretton Scott, E.; Pan Zhou, X.; Bergelson, S.; Qu, L.; Tausek, M.; Bridges, E.; Moussa, A.; Storer, R.; Pierra, C.; Benzaria, S.; Go 2003: NM 283 has potent antiviral activity against genotype 1 chronic hepatitis C virus infection in the chimpanzee. Journal of Hepatology 38(Suppl 2): 3

Escudero, C.; Santos, M.; Buján, J.; Fuente, M.; Honduvilla, N.G.; Bañas, E.; San Román, J.; Tendillo, F.J. 2001: Optical aggregometry versus the PFA-100: experimental studies in pigs treated with propofol. Platelets 12(3): 133-137

Agata, N.; Milhollen, M.; Umanoff, H.; Weitman, S.; Kharbanda, S. 2002: NM-3, a novel antiangiogenic agent, induces G2 cell cycle arrest in human multiple myeloma cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 980

Agata, N.; Tsuchiya, A.; Isshiki, K.; Rice, G.; Kufe, D.; Kharbanda, S. 2001: NM-3, a novel orally bioavailable antiangiogenic agent, suppresses hypoxia-induced vascular endothelial growth factor in human fibroblasts and tumor cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 587

Postel, E.H. 2001: NM23/NDP kinase A new family of DNA repair proteins?. International Journal of Molecular Medicine 8(Suppl 1): S34

Reimer, C.L.; Rice, G.C.; Tammam, J.; Bamberg, M.; Dickerson, W.M.; Kamphaus, G.D.; Rook, S.L.; Kufe, D.; Kharbanda, S.M. 2001: NM3 and paclitaxel combination therapy exhibit synergy in a human breast tumor xenograft model. Proceedings of the American Association for Cancer Research Annual Meeting 42: 72

Yin, L.; Agata, N.; Pu, M.; Weitman, S.; Kufe, D.; Kharbanda, S.M. 2003: NM3, a small molecule isocoumarin derivative, inhibits expression of the MUC1 glycoprotein in breast carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 451

Salloum, R.M.; Jaskowiak, N.T.; Beckett, M.A.; Mauceri, H.J.; Seetharam, S.; Kufe, D.W.; Weichselbaum, R.R. 2000: NM3, an isocoumarin, in selectively cytotoxic to endothelial cells in vitro and enhances tumor response to ionizing radiation. Proceedings of the American Association for Cancer Research Annual Meeting 41: 371

Laabich, A.; Li, G.; Cooper, N.G.F. 1999: NMDA alters the expression of calcium/calmodulin-dependent protein kinase II containing a nuclear localizing signal. Society for Neuroscience Abstracts 25(1-2): 134

Del Arco, A.; Mora, F. 2000: NMDA and AMPA glutamatergic agonists inhibit the stress induced dopamine release in the prefrontal cortex of the freely moving rat. European Journal of Neuroscience 12(Suppl 11): 467

Yasuda, S.; Ishida, N.; Higashiyama, A.; Morinobu, S.; Masui, A.; Kato, N. 1999: NMDA and AMPA receptors in the inferior colliculus differently play a critical role in both initiation and propagation of audiogenic seizures. Epilepsia 40(Suppl 2): 138

Silveri, M.M.; Spear, L.P. 2001: NMDA and GABAA receptors Their role in the responsivity and tolerance to ethanol during ontogeny. Developmental Psychobiology 38(3): 213

Huang, J.; Wang, H.; Pickel, V.M. 1999: NMDA and Mu opioid receptor colocalization in the rostral and intermediate nuclei of the solitary tract. Society for Neuroscience Abstracts 25(1-2): 1196

Stoop, R.; Pralong, E. 2000: NMDA and group I metabotropic glutamate receptor activation are necessary for the induction of persistent epileptic activity by bicuculline in the mouse limbic system. European Journal of Neuroscience 12(Suppl 11): 162

Orlando, L.R.; Dunah, A.W.; Standaert, D.G.; Penney, J.B.Jr; Young, A.B. 1999: NMDA and metabotropic receptors regulate tyrosine phosphorylation of striatal glutamate receptors. Society for Neuroscience Abstracts 25(1-2): 445

Stanojlovic, O.; Sucic, V.; Zivanovic, D. 1999: NMDA and metaphit-induced audiogenic seizures in rats. Epilepsia 40(Suppl 2): 138

Garcia, R.A.G.; Buonanno, A. 1999: NMDA and neuregulin receptor co-signaling mechanisms Interactions with PDZ domain proteins. Society for Neuroscience Abstracts 25(1-2): 771

Mao, J. 1999: NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Research. Brain Research Reviews 30(3): 289-304

Meyer, P.J.; Phillips, T.J. 2001: NMDA antagonism during chronic ethanol treatment. Alcoholism Clinical and Experimental Research 25(5 Suppl A): 61A

Franks, N.P.; Maze, M. 2001: NMDA antagonist. Official Gazette of the United States Patent and Trademark Office Patents 1249(2)

Mcguire, M.; Zhang, Y.; White, D.P.; Ling, L. 2002: NMDA antagonist MK-801 attenuates ventilatory long-term facilitation in awake rats. FASEB Journal 16(4): A69

Willner, J.; Marr, L. 1999: NMDA antagonist MK-801 reduces rats use of place strategies in problem-solving. Society for Neuroscience Abstracts 25(1-2): 633

Zhou, L.M.; Nielsen, J.S.; Xiong, Y.; Mccabe, R.T. 1999: NMDA antagonist activity of N-terminal fragments of conantokins. Society for Neuroscience Abstracts 25(1-2): 1716

Franks, N.P.; Maze, M. 2003: NMDA antagonist comprising xenon. Official Gazette of the United States Patent and Trademark Office Patents 1276(4)

Belger, A.; Kirino, E.; Madonick, S.; Gore, J.C.; Krystal, J.H. 2000: NMDA antagonist disruption of the frontal component of cortical activation during the processing of novel stimuli in humans An event-related fMRI study of the oddball task. Alcoholism Clinical and Experimental Research 24(5 Suppl): 13A

Newcomer, J.W.; Selke, G.; Melson, A.K.; White, D.A.; Roediger, H.L.; Farber, N.B.; Wozniak, D.; Jevtovic Todorovic, V.; Olney, J.W. 1999: NMDA antagonist-induced decreases in working and explicit memory in humans. Society for Neuroscience Abstracts 25(1-2): 633

Noguchi, K. 2002: NMDA antagonist-induced neurotoxicity and psychosis The dissociative stimulation hypothesis. Massaro Edward J , Reprint Author Handbook of Neurotoxicology 2: 199-222

Khanna, J.M.; Morato, G.S.; Ferreira, V.M.M. 1999: NMDA antagonists and tolerance to drugs affecting the central nervous system. CNS Drug Reviews 5(2): 165-176

Howell, A.; Awere, S.; Widzowski, D. 1999: NMDA antagonists do not exhibit clear alpha-4 nicotinic agonist or antagonist activity in several rat behavioral tasks. Society for Neuroscience Abstracts 25(1-2): 1717

Ikonomidou, C.; Turski, L. 1999: NMDA antagonists enhance delayed neurodegeneration in the hippocampus following traumatic brain injury. Society for Neuroscience Abstracts 25(1-2): 537

Castroman, P.J.; Ness, T.J. 2001: NMDA antagonists inhibit the reflex responses to urinary bladder distension in the rat. Regional Anesthesia and Pain Medicine 26(2 Suppl): 113

Woodhall, G.; Jones, R.S.G. 2000: NMDA auto- and heteroreceptors at synapses onto cortical neurones, probing for NR2B-containing receptors. Journal of Physiology (Cambridge) 527P: 100P

Strowbridge, B.W.; Friedman, D. 1999: NMDA autoreceptors mediate self-excitation of mitral cells in the rat olfactory bulb. Journal of Physiology (Cambridge) 518P: 137P

Danysz, W.; Parsons, C.G.; Quack, G. 1999: NMDA channel blockers Memantine and amino-alkylcyclohexanes-In vivo characterization. Amino Acids 17(1): 11

Marks, J.D.; Zhang, X.M. 1999: NMDA dissipates mitochondrial membrane potential in hippocampal neurons from postnatal rats only after the maturation of vulnerability to excitotoxicity. Society for Neuroscience Abstracts 25(1-2): 2130

Petrakis, I.; Trevisan, L.; Boutros, N.; O'malley, S.; Gelernter, J.; Krystal, J. 2000: NMDA dysregulation in individuals with a family vulnerability to alcoholism. Alcoholism Clinical and Experimental Research 24(5 Suppl): 12A

Gargiulo, P.A.; Martínez, G.; Ropero, C.; Funes, A.; Landa, A.I. 1999: NMDA glutamatergic blockade of nucleus accumbens disrupts acquisition but not consolidation in a passive avoidance task. Annals of the new York Academy of Sciences 877: 717-722

Saint Mieux, B.; Moore, L.E. 1999: NMDA induced conductances of Xenopus larval spinal neurons. Society for Neuroscience Abstracts 25(1-2): 1916

Yamamoto, S.; Tsuboi, T.; Sakurai, T.; Wakazono, Y.; Terakawa, S. 2003: NMDA induces acute nuclear DNA fragmentation through IP3 system in neurons. Neuroscience Research Suppl (26): S133

Goebel, D.J.; Poosch, M.S.; Yu, F.; Kim, H.R. 2001: NMDA induces caspase-3 activity in the rat retina. IOVS Investigative Ophthalmology and Visual Science 42(4): S748

Kruse, M.S.; Aizman, O.; Brismar, H.; Aperia, A. 2003: NMDA modulates the D1R-calcyon interaction and enhances calcium signaling. FASEB Journal 17(4-5): Abstract

Jackson, D.L.; Kobayashi, M.R. 1999: NMDA modulation of iCGRP release from dental pulp. Society for Neuroscience Abstracts 25(1-2): 1435

Zhu, Y.; Auerbach, A. 1999: NMDA pore mutations alter the kinetics, but not the affinity, of Mg+2 block. Biophysical Journal 76(1 Part 2): A334

Okada, S.; Yokotani, K.; Murakami, Y.; Nishihara, M.; Osumi, Y. 1999: NMDA produces thromboxane A2 in the brain and activates adrenomedullary outflow in rats. Japanese Journal of Pharmacology 79(Suppl 1): 252P

Wallace, L.J.; Battisti, J.J.; Uretsky, N.J. 1999: NMDA receptor activation and nitric oxide production mediate the expression of context-dependent and context-independent sensitization induced by amphetamine. Society for Neuroscience Abstracts 25(1-2): 609

Ahmed, S.M.; Weber, J.T.; Rzigalinski, B.A.; Ellis, E.F. 2000: NMDA receptor activation contributes to elevated intracellular calcium and decreased mitochondrial membrane potential in stretch-injured neurons. Journal of Neurotrauma 17(10): 957

Reines, A.; Pena, C.; Rodriguez, D.L.res Arnaiz, G. 2001: NMDA receptor activation favors its allosteric modulation by an endogenous Na+, K+-ATPase inhibitor. Journal of Neurochemistry 78(Suppl 1): 184

Potier, B.; Poindessous-Jazat, F.; Dutar, P.; Billard, J.M. 2000: NMDA receptor activation in the aged rat hippocampus. Experimental Gerontology 35(9-10): 1185-1199

Messaoudi, E.; Bramham, C.R. 1999: NMDA receptor activation is not required for BDNF-induced LTP in the rat dentate gyrus in vivo. Society for Neuroscience Abstracts 25(1-2): 467

Battisti, J.J.; Wallace, L.J.; Uretsky, N.J. 1999: NMDA receptor activation mediates the conditioned component of behavioral sensitization to amphetamine. FASEB Journal 13(5 Part 2): A1107

Torres, M.; Jurado, S. 2002: NMDA receptor activation regulates the NO/cGMP pathway in cerebellar granule cells in culture. Nitric Oxide 6(4): 479

Battisti, J.J.; Uretsky, N.J.; Wallace, L.J. 1999: NMDA receptor activation, but not nitric oxide production, mediates the development of context-dependent sensitization induced by apomorphine. Society for Neuroscience Abstracts 25(1-2): 609

Hong, J.; Kim, Y. 2003: NMDA receptor agonist pharmaceutical compositions. Official Gazette of the United States Patent and Trademark Office Patents 1275(3)

Krystal, J.H.; Petrakis, I.L.; Krupitsky, E.; Schutz, C.; Trevisan, L.; D'Souza, D.C. 2003: NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Annals of the new York Academy of Sciences 1003: 176-184

Zhang, Y.; Mcguire, M.; White, D.P.; Ling, L. 2002: NMDA receptor antagonist MK-801 abolishes phrenic long-term facilitation in rats. FASEB Journal 16(4): A69

Churchill, L. 1999: NMDA receptor antagonist attenuates motor responses to drugs of abuse when microinjected into the medial subthalamus and tuberal lateral hypothalamus. Society for Neuroscience Abstracts 25(1-2): 815

Huang, K.L.; Mao, S.P.; Kang, B.H.; Wan, F.J. 2000: NMDA receptor antagonist protects hyperbaric oxygen-induced neuron damage. FASEB Journal 14(4): A198

Sun, Miao Kun 2003: NMDA receptor antagonists as antidepressant and antidementia drugs Recent developments and future prospects. Current Medicinal Chemistry - Central Nervous System Agents 3(4): 323-334

Escobar, M.L.; Alcocer, I.; Bermudez Rattoni, F. 1999: NMDA receptor antagonists impairs conditioned taste a version and insular cortex long-term potentiation in vivo. Society for Neuroscience Abstracts 25(1-2): 1997

Kim Han, J.; Dugan, L. 2003: NMDA receptor antagonists induce free radical generation and cell death in developing neurons in vitro. Free Radical Biology and Medicine 35(Suppl 1): S158

Hipolide, D.C.; Nobrega, J.N.; Siga, D.; Tufik, S. 2002: NMDA receptor binding after REM sleep deprivation in rats Study autoradiographyic. Journal of Sleep Research 11(Suppl 1): 99

Covasa, M.; Ritter, R.C.; Burns, G.A. 1999: NMDA receptor blockade accelerates gastric emptying. Amino Acids 17(1): 39

Fiske, B.K.; Brunjes, P.C. 1999: NMDA receptor blockade and cell death in the developing rat olfactory bulb. Society for Neuroscience Abstracts 25(1-2): 223

Luthi, A.; Gahwiler, B.H.; Mckinney, R.A.ne 1999: NMDA receptor blockade does not prevent functional synaptogenesis in developing hippocampal slice cultures. Society for Neuroscience Abstracts 25(1-2): 732

Hammonds, M.D.; Woodside, B.L.; Teyler, T.J. 1999: NMDA receptor blockade impairs acquisition and retention in an odor discrimination digging task whereas VDCC blockade does not. Society for Neuroscience Abstracts 25(1-2): 632

Huang, L.; Pallas, S.L. 1999: NMDA receptor blockade in developing superior colliculus prevents map plasticity without blocking retinotectal transmission. Society for Neuroscience Abstracts 25(1-2): 1005

Ceglia, I.; Carli, M.; Invernizzi, R.W. 2003: NMDA receptor blockade increases glutamate efflux in the medial prefrontal cortex Role of 5-HT2A receptors. European Neuropsychopharmacology 13(Suppl 4): S103-S104

Wyneken, U.; Marengo, J.J.; Cheyre, J.E.; Cardemil, C.; Orrego, F. 1999: NMDA receptor channel regulation by endogenous modulators present in isolated PSDs A patch clamp study. Society for Neuroscience Abstracts 25(1-2): 734

Yeung, G.; Janssen, W.G.M.; Morrison, J.H.; Labowitz, D.A.; Rosenberg, J.J.; Gore, A.C. 1999: NMDA receptor colocalization in GnRH neurons decreases during reproductive aging in female rats. Society for Neuroscience Abstracts 25(1-2): 1959

Sharp, C.D.; Hines, I.N.; Warren, A.C.; Elrod, J.W.; Jennings, M.; Laroux, F.S.; Jawahar, A.; Fowler, M.; Alexander, J.S. 2002: NMDA receptor dependent oxygen radicals disrupt junctional barrier in human brain endothelial monolayers. FASEB Journal 16(5): A1124

Low, C.M. 2004: NMDA receptor desensitization Its implications in learning and memory?. Journal of Neurochemistry 88(Suppl 1): 17

Hynd, M.R.; Scott, H.L.; Dodd, P.R. 2003: NMDA receptor dysfunction in Alzheimers disease. Journal of Neurochemistry 87(Suppl 1): 108

Scholz, B.; Sobottka, H.; Allgaier, C. 2004: NMDA receptor expression in rat cultured mesencephalic neurones - Implications for the effect of ethanol on dopamine release. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R85

Cooper, N.G.; Li, G.Y.; Liu, O.L. 2000: NMDA receptor expression in the retina is regulated by photoreceptor activity. IOVS Investigative Ophthalmology and Visual Science 41(4): S13

Benveniste, M.; Nahum Levy, R. 2000: NMDA receptor glutamate site apparent affinity is modulated by ion permeation. Biophysical Journal 78(1 Part 2): 356A

Jentsch, J.D.; Grace, A.A.; Roth, R.H. 2000: NMDA receptor hypofunction and animal models of schizophrenia. European Neuropsychopharmacology 10(Suppl 3): S209-S210

Kim Han, J.S.; Lovett, E.; Rothman, S.M.; Dugan, L.L. 1999: NMDA receptor inhibition induces free radical generation and cell death of cortical neurons. Society for Neuroscience Abstracts 25(1-2): 1777

Placantonakis, D.G.; Welsh, J.P. 1999: NMDA receptor involvement in subthreshold oscillations of the inferior olive. Society for Neuroscience Abstracts 25(1-2): 1560

Ponomarev, I.; Crabbe, J.C. 2002: NMDA receptor involvement in very rapid adaptation to ethanol-induced sedation. Alcoholism Clinical and Experimental Research 26(5 Suppl): 18A

Scalzo, F. 2003: NMDA receptor mechanisms and neurobehavioral development in zebrafish. Neurotoxicology and Teratology 25(3): 381

Reines, A.; Zarate, S.; Pena, C.; Rodriguez, D.L.res Arnaiz, G. 2002: NMDA receptor modulation by a brain endogenous factor Effects of zinc, spermidine and pH. Journal of Neurochemistry 81(Suppl 1): 28

Lynch, D.R.; Guttmann, R.P. 2001: NMDA receptor pharmacology: perspectives from molecular biology. Current Drug Targets 2(3): 215-231

Wernicke, C.; Samochowiec, J.; Schmidt, L.G.; Rommelspacher, H. 2002: NMDA receptor polymorphisms in alcoholic patients. Alcoholism Clinical and Experimental Research 26(5 Suppl): 7A

Akyol, Z.; Hell, J.W.; Shea, M.A. 2003: NMDA receptor recognition by calmodulin. Biophysical Journal 84(2 Part 2): 60a-61a

Ali, D.W.; Salter, M.W. 2001: NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Current Opinion in Neurobiology 11(3): 336-342

Olavarria, J.F.; Van Brederode, J.F.M.; Spain, W.J. 1999: NMDA receptor responses during development of visual callosal connections in normal and deafferented rats. Society for Neuroscience Abstracts 25(1-2): 1005

Woodward, J.J. 2001: NMDA receptor rundown following PKA stimulation is NR2 subunit-selective Implications for adaptation to chronic alcohol. Alcoholism Clinical and Experimental Research 25(5 Suppl A): 106A

Heinz, L.J.; Lunn, W.H.W.; Ornstein, P.L. 1999: NMDA receptor selective antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1220(2): 1565

Campusano, J.; Plachez, C.; Tapia Arancibia, L.; Bustos, G. 2000: NMDA receptor subunit 1 expression is modulated by glutamate receptor agonists and BDNF in mesencephalic cultures. Biocell 24(Suppl): 54